Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1050.Time spend outdoors in summer,49663,-0.0213643505304346,0.0346268988665521,-0.0892330723088768,0.0465043712480075,0.537250085597265
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1060.Time spent outdoors in winter,47580,-0.0321557126604185,0.0380832583504097,-0.106798899027221,0.0424874737063845,0.3984831757695
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X1070.Time spent watching television (TV),50844,0.0145679922470815,0.0367268467383533,-0.057416627360091,0.086552611854254,0.691623692543821
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X1080.Time spent using computer,47638,0.0266319541927397,0.0354775663407716,-0.0429040758351726,0.096167984220652,0.452860698332529
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X1090.Time spent driving,43520,0.00524763135403725,0.0435021382791951,-0.0800165596731851,0.0905118223812596,0.903986372725606
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1160.Sleep duration,51628,0.0311400278725696,0.032237355992772,-0.0320451898732634,0.0943252456184027,0.334074121505564
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35464,-0.00680743367633389,0.016362248782894,-0.0388774412908061,0.0252625739381383,0.677391230038451
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35464,-0.00948771385396979,0.0158040803264664,-0.0404637112938439,0.0214882835859043,0.548305904854696
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35464,0.0278757793759031,0.0171768253230387,-0.00579079825725286,0.061542357009059,0.104667161501686
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35464,-4.19674815887279e-07,0.0171715032014626,-0.0336565659496826,0.0336557266000508,0.999980500326553
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35464,-0.00700761938261015,0.0173547304020876,-0.0410228909707018,0.0270076522054815,0.686382921488725
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35464,0.0616381034934568,0.0435797348558927,-0.0237781768240928,0.147054383811006,0.157301372671148
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35464,0.0771979231575043,0.0459321176730472,-0.0128290274816682,0.167224873796677,0.0928718017092219
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35464,0.0339875461003309,0.0293328765683004,-0.023504891973538,0.0914799841741997,0.246628985559536
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35464,-0.0133909922672966,0.0216408841229719,-0.0558071251483215,0.0290251406137282,0.536082378564396
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35464,0.00856958481468758,0.014083100689379,-0.0190332925364952,0.0361724621658704,0.542877099130887
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35464,-0.00975190844075287,0.0212807447596039,-0.0514621681695766,0.0319583512880709,0.646788481475359
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35464,-0.00886217374672011,0.0113258896882371,-0.0310609175356648,0.0133365700422246,0.433967707772608
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35464,-0.00732601521566288,0.0148693121702272,-0.0364698670693082,0.0218178366379824,0.622246339883527
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35464,0.0156769013932832,0.0213254228085442,-0.0261209273114634,0.0574747300980298,0.462289438427921
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35464,-0.00314958364049858,0.02014637603842,-0.0426364806758018,0.0363373133948046,0.875774004885489
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35464,0.00441092666144355,0.030733404164383,-0.0558265455007471,0.0646483988236342,0.885882369175619
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35464,-0.00766513167406913,0.0289358313817221,-0.0643793611822445,0.0490490978341063,0.791094408888618
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35464,-0.0136003422180985,0.0154180156217663,-0.0438196528367603,0.0166189684005634,0.377752667273925
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35464,0.0271551887018779,0.0146235878391118,-0.00150704346278116,0.055817420866537,0.0633659366756459
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35464,-0.000656674170612496,0.0184709364766159,-0.0368597096647797,0.0355463613235548,0.971640911255851
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120040.Fatigue severity over the past week,35469,0.0195208159918941,0.0649795720989988,-0.107839145322143,0.146880777305932,0.763870838634225
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120041.Waking unrefreshed severity over the past week,35466,-0.0418247305185957,0.0632524716955882,-0.165799575041949,0.0821501140047573,0.508486093522248
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120042.Cognitive symptoms severity over the past week,35468,-0.138606111102361,0.0707408527155436,-0.277258182424826,4.59602201043074e-05,0.0501160082843406
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120098.Mobility problems today,35472,0.0514134018015174,0.0687052403149221,-0.0832488692157299,0.186075672818765,0.454296118637302
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120099.Self-care problems today,35472,0.0540905162122004,0.0999451361150041,-0.141801950573208,0.249982982997608,0.588387511632026
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120100.Problems doing usual activities,35472,0.107502439397904,0.0651380752964302,-0.0201681881830991,0.235173066978907,0.0989157159880851
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120101.Pain or discomfort today,35472,-0.035054730627077,0.0638531365268735,-0.160206878219749,0.0900974169655949,0.583031876070549
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120102.Anxiety or depression today,35472,-0.170753143910025,0.0891269648164657,-0.345441994950298,0.00393570713024741,0.0554306568232266
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120103.Scale to indicate how health is today,35450,-0.000709828904064928,0.00495543870917768,-0.0104224887740532,0.00900283096592333,0.886103362741105
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35448,-0.086243031074892,0.08507659127697,-0.252993149977753,0.0805070878279691,0.31076015635812
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35440,-0.0148741395604383,0.0840591482481109,-0.179630070126736,0.149881791005859,0.859554587204685
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35453,-0.0678535503774665,0.0626839099602305,-0.190714013899518,0.0550069131445853,0.279084755670601
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35452,-0.000177678385848092,0.0636653714607865,-0.12496180644899,0.124606449677294,0.997773342267054
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35463,0.0339585078247071,0.0895084037472896,-0.14147796351998,0.209394979169395,0.704411838451945
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120109.Feeling bad about self over the last two weeks,35444,0.0106146683588903,0.0890901124543474,-0.164001952051631,0.185231288769411,0.905164070900833
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120110.Trouble concentrating over the last two weeks,35457,-0.00442327297201305,0.0895338245775103,-0.179909569143933,0.171063023199907,0.960599415665458
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35455,0.105861869977694,0.111629845133463,-0.112932626483893,0.324656366439281,0.342998373948166
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35438,-0.463604346432114,0.254486770137068,-0.962398415900768,0.0351897230365398,0.0685448958546727
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33348,-0.00853614122415321,0.0904652120957607,-0.185847956931844,0.168775674483538,0.924829113883721
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49858,-0.00411959530029214,0.0806964840672816,-0.162284704072164,0.15404551347158,0.959285778780157
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48117,-0.0741515269101328,0.053830444362274,-0.17965919786019,0.0313561440399243,0.168373491789076
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1289.Cooked vegetable intake,51183,-0.0182750377072588,0.0334910740117642,-0.0839175427703166,0.047367467355799,0.585299085106247
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50390,0.0107673386323612,0.0353525259575903,-0.0585236122445158,0.0800582895092381,0.760696235239483
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1309.Fresh fruit intake,51101,-0.0136233419547662,0.0343458448157241,-0.0809411977935855,0.0536945138840531,0.691628095405947
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1319.Dried fruit intake,49929,-0.0140731844104024,0.0353442358316209,-0.0833478866403793,0.0552015178195745,0.690505432052367
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X134.Number of self-reported cancers,51835,-0.0920674475563806,0.0585943781814616,-0.206912428792045,0.0227775336792842,0.116134480923154
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X135.Number of self-reported non-cancer illnesses,51836,0.00188461778936806,0.0348301132679998,-0.0663824042159116,0.0701516397946477,0.956848909206211
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X136.Number of operations, self-reported",51836,-0.0586069310958149,0.034294278077957,-0.125823716128611,0.00860985393698087,0.0874754043140373
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X137.Number of treatments or medications taken,51836,-0.050660669124648,0.03298173684066,-0.115304873332342,0.0139835350830456,0.124546989948639
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1438.Bread intake,51223,-0.00156456502922788,0.00279168913720048,-0.00703627573814083,0.00390714567968507,0.575187308602731
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1458.Cereal intake,50887,-0.0296017132615379,0.032705142204468,-0.0937037919822953,0.0345003654592194,0.365417782784916
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1488.Tea intake,51145,-0.00315481118207179,0.00271390849796282,-0.00847407183807891,0.00216444947393533,0.245061135492658
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1498.Coffee intake,50169,0.0152517301014527,0.0331604278895043,-0.0497427085619758,0.0802461687648812,0.645565724479109
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1528.Water intake,50003,0.0743694977521793,0.0347502830154679,0.00625894304186225,0.142480052462496,0.0323573093046868
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1568.Average weekly red wine intake,44659,0.0549213107142806,0.0384685538437497,-0.0204770548194688,0.13031967624803,0.153400242923048
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,44659,0.0775053236358827,0.039009207748455,0.00104727644891084,0.153963370822854,0.0469569817624445
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1588.Average weekly beer plus cider intake,44705,-0.00287285781574924,0.0450065745840448,-0.0910857440004771,0.0853400283689786,0.949104853268208
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1598.Average weekly spirits intake,44640,-0.00701713761544797,0.0412437596297515,-0.087854906489761,0.0738206312588651,0.864903707483859
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1608.Average weekly fortified wine intake,44690,0.138451696704466,0.0564024185628155,0.0279029563213478,0.249000437087585,0.0141106619212239
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1737.Childhood sunburn occasions,45647,-0.0133808911897856,0.040706167682978,-0.0931649798484226,0.0664031974688514,0.742372267238513
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X1807.Father's age at death,49735,0.0012431970783858,0.00263543575701841,-0.00392225700537029,0.00640865116214189,0.63712914472122
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X1845.Mother's age,32521,-0.0244936774221062,0.0133503883912934,-0.0506604386690413,0.00167308382482893,0.066642504922803
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X1873.Number of full brothers,51418,0.0172581964872289,0.0317441202490508,-0.0449602792009107,0.0794766721753685,0.586676838807806
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X1883.Number of full sisters,51424,-0.0438890883086326,0.0322669471352443,-0.107132304693711,0.0193541280764462,0.173784487054112
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X20015.Sitting height,51674,0.00305913940448677,0.0034803391529122,-0.00376232533522114,0.00988060414419469,0.379422933458917
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20016.Fluid intelligence score,36579,0.0266203603289704,0.0550873210714066,-0.0813507889709865,0.134591509628927,0.628940159057318
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20018.Prospective memory result,36931,0.0106888365000853,0.0655468152326958,-0.117782921355998,0.139160594356169,0.870466170141874
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36458,-0.00881758390000285,0.00463713408812149,-0.017906366712721,0.000271198912715282,0.0572740088484234
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36444,-0.00507296968868714,0.00466662474962295,-0.0142195541979481,0.00407361482057384,0.277039938083135
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20023.Mean time to correctly identify matches,51533,0.00406902779166874,0.00282633362123486,-0.00147058610595159,0.00960864168928906,0.149970784791924
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#1.Illnesses of father_Heart disease,48458,-0.00736983895917439,0.005918898669249,-0.0189708803509024,0.00423120243255365,0.213096589255783
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48008,0.0035456435200378,0.0126071208302723,-0.0211643133072959,0.0282556003473715,0.778528393989583
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,47975,-0.00450882642057678,0.0168176587239694,-0.0374714375195568,0.0284537846784033,0.788624735647652
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#12.Illnesses of father_Severe depression,47982,0.0285750799202746,0.0161903374912326,-0.00315798156254126,0.0603081414030904,0.0775889968141689
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48005,0.010306773143297,0.0111797462376041,-0.0116055294824071,0.0322190757690011,0.356584859656207
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#2.Illnesses of father_Stroke,48175,-0.00568835567953778,0.00745195818664829,-0.0202941937253684,0.00891748236629288,0.445271906716713
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48123,0.00357000814518481,0.00925391546348375,-0.0145676661632433,0.021707682453613,0.699661331731496
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48024,-0.0104126206030834,0.0118436614188289,-0.033626196983988,0.0128009557778212,0.379319008886485
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48175,-0.000673433750472446,0.00803118139575191,-0.0164145492861462,0.0150676817852013,0.933174678140453
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48165,-0.0101696312643783,0.00747069277301083,-0.0248121890994796,0.0044729265707229,0.17344449224117
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#9.Illnesses of father_Diabetes,48049,0.000506502294224204,0.0106716645129055,-0.0204099601510707,0.0214229647395191,0.962145238176844
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49550,-0.00311794392376728,0.00634534244469646,-0.0155548151153723,0.00931892726783778,0.623166397986773
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49390,-0.00348945419723905,0.00826894744763231,-0.0196965911945984,0.0127176828001203,0.67303318364033
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49302,0.0232528138973304,0.0182939389801252,-0.0126033065037149,0.0591089342983757,0.203719677787617
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49326,-0.0156150552103335,0.0114884790120865,-0.0381324740740231,0.00690236365335602,0.174100803008066
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#2.Illnesses of mother_Stroke,49480,0.00184989799648644,0.00696409584328044,-0.0117997298563432,0.0154995258493161,0.790524088971004
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49347,0.0140071025836823,0.0134876608414624,-0.0124287126655839,0.0404429178329486,0.299044040356877
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49331,0.0138988030988527,0.0112388182708211,-0.00812928071195672,0.0359268869096621,0.21622094671014
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49337,0.0109524377094453,0.00989339053896633,-0.00843860774692866,0.0303434831658194,0.268287291728508
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49384,0.0219603128569484,0.0111210207143677,0.000163112256787674,0.0437575134571091,0.048319551406227
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49524,-1.12656593514416e-07,0.00617231481236847,-0.0120978496888357,0.0120976243756487,0.999985437254252
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49396,-0.000565332337020163,0.00944776099072038,-0.0190829438788321,0.0179522792047918,0.952285486832715
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,45821,-0.000895059437244071,0.00830254006491311,-0.0171680379644738,0.0153779190899856,0.914151285083804
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,45649,0.00344247842858175,0.0291335082270763,-0.0536591976964878,0.0605441545536513,0.905940609503161
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,45639,-0.050416274610556,0.0307802806364666,-0.110745624658031,0.0099130754369185,0.101453194950474
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,45672,-0.00546408270031516,0.0126806185691053,-0.0303180950957615,0.0193899296951312,0.666546481297433
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,45666,8.382215316333e-05,0.0172212015968285,-0.0336697329766206,0.0338373772829473,0.996116465953948
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#2.Illnesses of siblings_Stroke,45699,0.00849175880645366,0.0137733340443427,-0.018503975920458,0.0354874935333653,0.537549201896014
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,45662,0.00746376320059638,0.0154357842357693,-0.0227903739015114,0.0377179003027042,0.628721365431435
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,45657,-0.0053440708206689,0.0157137050947751,-0.0361429328064281,0.0254547911650903,0.733793241877458
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,45676,0.0075561268956998,0.0126996357076474,-0.017335159091289,0.0324474128826886,0.551859868631356
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,45692,-0.00306602543019527,0.0149551353607328,-0.0323780907372315,0.026246039876841,0.837563020821811
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,45865,-0.00547325708987568,0.0069796184456772,-0.019153309243403,0.00820679506365164,0.43294733032023
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,45758,-0.0055938777476745,0.00962564867334729,-0.0244601491474352,0.0132723936520862,0.561152029241389
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20127.Neuroticism score,46965,0.0302227703283542,0.0333511028334253,-0.0351453912251594,0.0955909318818678,0.364842282065015
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36579,-0.0302593259830294,0.0529724559161468,-0.134085339578677,0.0735666876126184,0.567862816891314
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X20161.Pack years of smoking,36872,0.00243207148662886,0.00454186708279665,-0.00646998799565256,0.0113341309689103,0.592334632420079
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36872,0.00137853442606957,0.00469077524717857,-0.00781538505840042,0.0105724539105396,0.768856013177904
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20191.Fluid intelligence score,34244,-0.0262779692899462,0.0645743722338543,-0.152843738868301,0.100287800288408,0.684068499400056
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34245,0.0171697664780549,0.0649994035683873,-0.110229064515984,0.144568597472094,0.791673076670325
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20240.Maximum digits remembered correctly,33617,0.071793132938859,0.0689154268143635,-0.0632811036172935,0.206867369495011,0.297581364803578
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X20255.Spirometry QC measure,45913,0.0103104396058895,0.0419241952133033,-0.071860983012185,0.0924818622239639,0.805739027430304
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X20261.avMSE,34237,0.00751530658506556,0.00521780676161081,-0.00271159466769163,0.0177422078378228,0.149839225492146
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X20262.Myopia diagnosis,34237,-0.182101968644836,0.0954247734950002,-0.369134524695037,0.00493058740536406,0.0564052975289706
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X20280.Glucose-lactate,42313,0.00262435622180162,0.00356001383685702,-0.00435327089843814,0.00960198334204139,0.461028601743953
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X20281.Spectrometer-corrected alanine,42341,0.00826946358803899,0.00365030623420487,0.00111486336899743,0.0154240638070805,0.0235033360709564
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,36281,0.0123724742836097,0.0216354879227879,-0.0300330820450545,0.0547780306122739,0.567434831535916
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,36281,0.0306983038401576,0.0405962173142964,-0.0488702820958634,0.110266889776179,0.449562632889507
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),36281,-0.0996606336780969,0.0676491165949226,-0.232252902204145,0.0329316348479514,0.140741704963177
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),36281,0.0048778564558351,0.0198364409372818,-0.0340015677812373,0.0437572806929074,0.805763813392759
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),36281,-0.0198227314578489,0.0407379651212183,-0.0996691430954368,0.060023680179739,0.626563175376571
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,36285,-0.0572127390328644,0.0521297712814037,-0.159387090744416,0.0449616126786869,0.272457506844639
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,36285,-0.0134181618214451,0.0321894027656484,-0.0765093912421159,0.0496730675992258,0.676800534810094
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,36285,-0.00236720344952899,0.0392592735647701,-0.0793153796364784,0.0745809727374204,0.951921053543459
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,36285,-0.0491784820735673,0.0620309853308899,-0.170759213322111,0.072402249174977,0.427917903550066
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,36285,-0.0553887021153898,0.0709918140251714,-0.194532657604726,0.0837552533739463,0.435291836032201
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,36285,-0.0766287739902694,0.0421798907014919,-0.159301359765193,0.0060438117846547,0.0693032024541548
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,36285,-0.0555342852376005,0.0735479703188861,-0.199688307062617,0.0886197365874163,0.450228639526213
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,36285,-0.0363280114307228,0.0503346420090294,-0.13498390976842,0.0623278869069749,0.470484409985242
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),36283,-0.0273734550292777,0.069799966048716,-0.164181388484761,0.109434478426206,0.69494437348332
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),36283,-0.0017209310481792,0.0268850503257452,-0.0544156296866397,0.0509737675902813,0.948963507043325
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),36283,-0.0131155622926605,0.0491013514371319,-0.109354211109439,0.0831230865241181,0.789390665412083
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,36285,0.0146526506530068,0.085516051251639,-0.152958809800206,0.182264111106219,0.863958281004695
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20600.Liking for adding salt to foods,36100,-0.0374646161766651,0.05473963974875,-0.144754310084215,0.0698250777308849,0.493736308883037
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20601.Liking for aniseed,36100,-0.140393257004132,0.0555418059548482,-0.249255196675635,-0.0315313173326298,0.0115032492723541
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20602.Liking for apple juice,36100,0.0199501921896756,0.0545490735650912,-0.0869659919979031,0.126866376377254,0.714578328037274
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20603.Liking for apples,36100,0.0237534722519214,0.0561162997532208,-0.0862344752643913,0.133741419768234,0.672096839273348
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20604.Liking for asparagus,36100,0.0308527598957425,0.0534899318877342,-0.0739875066042166,0.135693026395702,0.5640963344566
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20605.Liking for aubergine,36100,-0.0403947979868915,0.0518476121656461,-0.142016117831558,0.0612265218577748,0.435943867459452
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20606.Liking for avocados,36100,-0.00408779563170187,0.0523770154487685,-0.106746745911288,0.0985711546478844,0.937794043497274
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20607.Liking for bacon,36100,-0.00744664214492918,0.0522124949256345,-0.109783132199173,0.0948898479093144,0.886593013332618
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20608.Liking for baked or steamed fish,36100,0.0184330440905749,0.0521547632707594,-0.0837902919201135,0.120656380101263,0.723777100197019
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20609.Liking for bananas,36100,0.00622895839168457,0.0522765825694468,-0.0962331434444312,0.1086910602278,0.905156903630619
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36100,-0.00523133500545728,0.0518861546577579,-0.106928198134663,0.0964655281237482,0.919693635442643
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20611.Liking for beef steak,36100,-0.00694072746116374,0.0541163011400616,-0.113008677695684,0.0991272227733569,0.897950311793297
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20612.Liking for beetroot,36100,0.00357445667471078,0.0529690449849802,-0.10024487149585,0.107393784845272,0.94619995364262
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20613.Liking for bell pepper,36100,-0.0208838505281221,0.0539909746677588,-0.126706160876929,0.0849384598206852,0.698914269886233
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20614.Liking for bicycling,36100,-0.154677927296707,0.0540181181109099,-0.26055343879409,-0.0488024157993232,0.00420325090983636
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20615.Liking for biscuits,36100,0.0317906691583474,0.0547725866936893,-0.0755636007612837,0.139144939077979,0.561655745141481
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20616.Liking for bitter foods,36100,-0.0687433765319377,0.0517522999653446,-0.170177884464013,0.0326911314001378,0.184117888617178
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20617.Liking for bitter or ale,36100,-0.0384730274457413,0.0548563615507566,-0.145991496085224,0.0690454411937416,0.483113758844177
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20618.Liking for black olives,36100,-0.0569731937860702,0.0509432063800643,-0.156821878290996,0.0428754907188558,0.263449292835698
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20619.Liking for black pepper,36100,-0.042272504668733,0.0520833065832244,-0.144355785571853,0.0598107762343868,0.417030542266454
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20620.Liking for blue cheese,36100,-0.0357474197803159,0.0539760418423904,-0.141540461791401,0.0700456222307692,0.507811940540933
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20621.Liking for bolognese sauce,36100,0.0207004011325884,0.0537390008392233,-0.0846280405122893,0.126028842777466,0.700099219394694
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20622.Liking for broad beans,36100,-0.000669450758355052,0.0538619612048456,-0.106238894719852,0.104899993203142,0.990083701046176
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20623.Liking for broccoli,36100,-0.0137164395858379,0.0536425561285108,-0.118855849597719,0.0914229704260433,0.798189573568289
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20624.Liking for brown rice,36100,-0.0281165524766812,0.0527829464252194,-0.131571127470111,0.0753380225167488,0.594270535105908
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20625.Liking for brussel sprouts,36100,-0.0139122559735169,0.0514839233564057,-0.114820745752072,0.0869962338050383,0.786995054813898
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20626.Liking for burgers (meat),36100,0.0215349535439749,0.054166869871414,-0.0846321114039965,0.127702018491946,0.690961780563007
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20627.Liking for burn of spicy foods,36100,-0.130211270607979,0.0560534358478109,-0.240076004869689,-0.0203465363462698,0.0202089180648763
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20628.Liking for butter on bread,36100,0.0947797227262124,0.0529710821638779,-0.00904359831498822,0.198603043767413,0.0736147374997709
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20629.Liking for butternut squash,36100,0.0069406225115467,0.0520430486594152,-0.0950637528609071,0.108944997884001,0.893910114266516
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20630.Liking for cabbage,36100,0.0456020196143911,0.052476507275571,-0.0572519346457282,0.14845597387451,0.384878048960664
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20631.Liking for cake,36100,0.0120351196348058,0.0521014702753251,-0.0900837621048315,0.114154001374443,0.817326425243413
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20632.Liking for cake icing,36100,0.0474254521121435,0.0534178401760713,-0.0572735146329563,0.152124418857243,0.374668287992184
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20633.Liking for capers,36100,0.000392359304836063,0.0532403748175819,-0.103958775337624,0.104743493947297,0.994120190714567
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20634.Liking for cauliflower,36100,-0.0694945711452983,0.0535440756154154,-0.174440959351513,0.0354518170609159,0.194366929785026
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20635.Liking for cereal or granola bar,36100,0.0682703496004284,0.0508036217226033,-0.0313047489758742,0.167845448176731,0.179054455829925
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20636.Liking for cheesecake,36100,0.0481490443114775,0.0524618241866498,-0.0546761310943562,0.150974219717311,0.358759846461098
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20637.Liking for cherries,36100,0.0919749391860653,0.0562225479395841,-0.0182212547755196,0.20217113314765,0.101904386095055
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20638.Liking for chicken,36100,-0.0592905606221236,0.0565181375685182,-0.170066110256419,0.0514849890121722,0.294190167762755
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20639.Liking for chilli pepper,36100,-0.11717911438906,0.0544490066831939,-0.223899167488121,-0.0104590612900004,0.0314249341418701
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20640.Liking for chips or french fries,36100,0.0249489208101787,0.05242222486082,-0.0777986399170284,0.127696481537386,0.634144604861389
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20641.Liking for cigarette smoking,36100,0.0264798443033674,0.0947715086266521,-0.159272312604871,0.212232001211605,0.779940704540269
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20642.Liking for cod,36100,-0.0195636575079552,0.0539604405730883,-0.125326121031208,0.0861988060152979,0.716948024895048
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20643.Liking for coffee with sugar,36100,-6.49963327709161e-05,0.0572899554954132,-0.112353309103781,0.112223316438239,0.999094820739535
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20644.Liking for coffee without sugar,36100,-0.00716871365824912,0.0529203699905518,-0.110892638839731,0.0965552115232323,0.892250343428046
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20645.Liking for coriander,36100,-0.0670858987870756,0.0528103565139577,-0.170594197554433,0.0364223999802816,0.204014551370706
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20646.Liking for corn flakes,36100,0.0656774691935484,0.0543972427412325,-0.0409411265792673,0.172296064966364,0.227332005193143
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20647.Liking for cream,36100,0.0859799768119219,0.0512747293871632,-0.014518492786918,0.186478446410762,0.0936173375347679
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20648.Liking for croissant,36100,-0.0142836128324676,0.0535059975090572,-0.11915536795022,0.0905881422852846,0.789512951795056
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20649.Liking for cucumber,36100,0.0429192011221598,0.0514534261138718,-0.0579295140610289,0.143767916305348,0.40423273479111
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20650.Liking for curry,36100,-0.0902565634036155,0.0542236083861357,-0.196534835840441,0.0160217090332104,0.0960529401966338
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20651.Liking for dairy products,36100,0.0427420905274986,0.0545515619731693,-0.0641789709399132,0.14966315199491,0.433350324889533
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20652.Liking for dark chocolate,36100,0.0936611322831423,0.0546065608126154,-0.013367726909584,0.200689991475869,0.0863536190685287
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20653.Liking for diet fizzy drinks,36100,-0.00548864800768386,0.0551964030617174,-0.11367359800865,0.102696301993282,0.920792998683086
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20654.Liking for dried fruit,36100,0.0310090665945614,0.0522998459509884,-0.0714986314693758,0.133516764658499,0.553261273771895
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20655.Liking for eggs,36100,0.0508350596069354,0.0530965561430572,-0.0532341904334567,0.154904309647328,0.338394996304572
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20656.Liking for exercising alone,36100,-0.117635088175303,0.0538168638115579,-0.223116141245956,-0.0121540351046493,0.0288607753766669
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20657.Liking for exercising with others,36100,-0.078450502260092,0.0518830694873594,-0.180141318455316,0.0232403139351325,0.130563492821279
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20658.Liking for extra virgin olive oil,36100,-0.0746362736730336,0.0524852495854931,-0.1775073628606,0.0282348155145329,0.155059032621445
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20659.Liking for fatty foods,36100,0.0766698906657938,0.052116473373775,-0.0254783971468052,0.178818178478393,0.141302709568786
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20660.Liking for fresh tomatoes,36100,-0.0469726435673165,0.0557585571632048,-0.156259415607198,0.062314128472565,0.399576896502875
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20661.Liking for fried chicken,36100,-0.0524127371108543,0.0520844183629362,-0.154498197102209,0.0496727228805006,0.314304857379528
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20662.Liking for fried or battered fish,36100,-0.00765884789440496,0.052650004096267,-0.110852855923088,0.0955351601342784,0.884346273437322
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20663.Liking for fruit,36100,0.000196474775722994,0.059878914087391,-0.117166196835563,0.117559146387009,0.997382079669088
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20664.Liking for garlic,36100,-0.0562808211618183,0.0517058655845669,-0.157624317707569,0.0450626753839328,0.276421118328972
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20665.Liking for gherkins,36100,-0.00257139037816842,0.0517357805903924,-0.103973520335338,0.0988307395790007,0.960361015197247
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20666.Liking for globe artichoke,36100,-0.0284883432797719,0.0546717005620927,-0.135644876381473,0.0786681898219298,0.602327599413724
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20667.Liking for goat's cheese,36100,-0.110392815232734,0.0524726979532206,-0.213239303221047,-0.00754632724442175,0.0354307564146171
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20668.Liking for going to a cafe,36100,-0.00733667897693373,0.0529706012433637,-0.111159057413927,0.0964856994600591,0.889845572906833
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20669.Liking for going to the gym,36100,-0.0923620610012545,0.052309450656085,-0.194888584287181,0.010164462284672,0.0774927927964237
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20670.Liking for going to the pub,36100,0.0729668343740098,0.0531341501601521,-0.0311760999398883,0.177109768687908,0.169717159415574
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20671.Liking for grapefruit,36100,0.0127334482132308,0.0525689188434896,-0.0903016327200088,0.11576852914647,0.808613883628046
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20672.Liking for green olives,36100,-0.0135696605381562,0.0519139176913829,-0.115320939213267,0.0881816181369543,0.793801331450261
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20673.Liking for haddock,36100,0.0209695616024717,0.0529345892460322,-0.0827822333197514,0.124721356524695,0.692013261094704
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20674.Liking for ham,36100,0.00871985247118323,0.0532646363809273,-0.0956788348354343,0.113118539777801,0.869965736699124
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20675.Liking for hard cheese,36100,-0.010202152005795,0.0547950367033948,-0.117600423944449,0.0971961199328588,0.852303185883606
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20676.Liking for herring,36100,0.0379286748330322,0.0536402000971376,-0.0672061173573575,0.143063467023422,0.479531823975866
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20677.Liking for honey,36100,-0.00876886653104568,0.0512433064437845,-0.109205747160863,0.0916680140987719,0.864132712465466
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20678.Liking for horseradish or wasabi,36100,-0.00917570892128795,0.0564186747499246,-0.11975631143114,0.101404893588564,0.870809786378508
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20679.Liking for ice cream,36100,0.00178731691450778,0.0522494163774522,-0.100621539185299,0.104196173014314,0.972712752046204
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20680.Liking for jam,36100,0.00220302050098015,0.0540287128960074,-0.103693256775194,0.108099297777155,0.967476454063025
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20681.Liking for kiwi fruit,36100,0.0193116852600897,0.0520804642931708,-0.0827660247545251,0.121389395274704,0.710794326684928
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20682.Liking for lager,36100,-0.0272546289120431,0.0542108642115294,-0.133507922766641,0.0789986649425545,0.615154587166987
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20683.Liking for lamb,36100,-0.00709381762380684,0.0520468237327028,-0.109105592139904,0.0949179568922906,0.891590599564082
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20684.Liking for lemons,36100,-0.0525839138938668,0.0518852403007147,-0.154278984883268,0.049111157095534,0.310873299770399
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20685.Liking for lentils or beans,36100,-0.077258357236441,0.0526534502126592,-0.180459119653253,0.025942405180371,0.142340319997708
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20686.Liking for liver,36100,0.0232752680709041,0.0523577428461231,-0.0793459079074972,0.125896444049305,0.656663996166605
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20687.Liking for mackerel,36100,0.0869597083671969,0.0516431246970318,-0.0142608160389854,0.188180232773379,0.0922542929429429
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20688.Liking for marzipan,36100,0.0300624579577647,0.0519415869014714,-0.0717430523691192,0.131867968284649,0.562760343375061
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20689.Liking for mayonnaise,36100,0.014743089213883,0.0532020466937084,-0.0895329223057856,0.119019100733551,0.781700050774734
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20690.Liking for melon,36100,0.0495540875774681,0.0551242452713895,-0.0584894331544554,0.157597608309392,0.368709252983459
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20691.Liking for milk chocolate,36100,-0.0503255796255974,0.0527517545443023,-0.15371901853243,0.0530678592812351,0.340113182489363
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20692.Liking for mushrooms,36100,0.0339272684856444,0.0525003937375616,-0.0689735032399763,0.136828040211265,0.5181526669725
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20694.Liking for orange juice,36100,0.0127242449084191,0.054202619589733,-0.0935128894874575,0.118961379304296,0.814407169162201
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20695.Liking for oranges,36100,-0.0591649617674445,0.0517030240530054,-0.160502888911335,0.0421729653764461,0.252529402258865
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20696.Liking for pasta,36100,-0.00972746521233409,0.0510660417397471,-0.109816907022238,0.0903619765975703,0.848932397196472
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20697.Liking for pears,36100,-0.0146841894719648,0.0528865268247229,-0.118341782048422,0.0889734031044921,0.781285807298178
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20698.Liking for pizza,36100,0.0251581845422243,0.0532768965363568,-0.079264532669035,0.129580901753484,0.636787807372699
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20699.Liking for plain yogurt,36100,-0.0475535437742942,0.051031127156355,-0.14757455300075,0.0524674654521616,0.351444764579337
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20700.Liking for plums,36100,0.0570274246655677,0.0540721833098656,-0.0489540546217689,0.163008903952904,0.291620707580637
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20701.Liking for pollock,36100,-0.0223822404668057,0.0528800053913572,-0.126027051033866,0.0812625701002544,0.672115331924988
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20702.Liking for pork chop,36100,0.0389845100275551,0.0525033783640875,-0.0639221115660564,0.141891131621167,0.457801068767441
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20703.Liking for porridge,36100,-0.0681173957251318,0.0546049609662557,-0.175143119218993,0.0389083277687294,0.212271963627151
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20704.Liking for potato crisps,36100,0.0374059666647099,0.054135916677697,-0.0687004300235762,0.143512363352996,0.489611452065589
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20705.Liking for potatoes,36100,-0.0500664123171265,0.0515984854926927,-0.151199443882804,0.0510666192485512,0.331927117297388
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20706.Liking for prawns,36100,0.0511714551489867,0.051653987927531,-0.0500703611889741,0.152413271486947,0.321887181488169
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20707.Liking for raw carrots,36100,0.0341418409343383,0.0512107560299688,-0.0662312408844005,0.134514922753077,0.504990697325134
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20708.Liking for red meat,36100,-0.0112973875616222,0.052159545024983,-0.113530095810589,0.0909353206873444,0.828532018665525
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20709.Liking for red wine,36100,-0.0443770092495524,0.0515745940873698,-0.145463213660797,0.0567091951616924,0.389574684855841
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36100,0.046171738603552,0.0548602560981028,-0.0613543633487295,0.153697840555834,0.400027320421324
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20711.Liking for roast chicken,36100,0.00914336715841137,0.0566338072957647,-0.101858895141287,0.12014562945811,0.871745957010261
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20712.Liking for salad dressing,36100,-0.00508600321905265,0.0536619567183007,-0.110263438386922,0.100091431948817,0.924493466678769
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20713.Liking for salad leaves,36100,-0.00162940692941099,0.0559111649511336,-0.111215290233633,0.107956476374811,0.976751557826198
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20714.Liking for salami,36100,-0.0352716361498062,0.0509236373648976,-0.135081965385005,0.064538693085393,0.488560202186441
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20715.Liking for salmon,36100,0.015255503853718,0.053657256931036,-0.0899127197311126,0.120423727438549,0.776178371902662
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20716.Liking for salty foods,36100,-0.0272235781431591,0.0518155580266719,-0.128782071875436,0.0743349155891179,0.599326282281923
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20717.Liking for salty pretzels,36100,0.0370528299342953,0.0509644022754678,-0.0628373985256215,0.136943058394212,0.467230083792996
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20718.Liking for sardines,36100,0.0620493299995233,0.0529462513510971,-0.041725322648627,0.165823982647674,0.241265416844781
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20719.Liking for sausages (meat),36100,0.00592607755066144,0.0519681545899553,-0.095931505445651,0.107783660546974,0.909215060117753
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20720.Liking for savoury biscuits,36100,0.0648323612011477,0.0519855082758511,-0.0370592350195205,0.166723957421816,0.21239447878847
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36100,0.0788082200928916,0.0517714713864924,-0.0226638638246336,0.180280304010417,0.127996660729219
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20722.Liking for skimmed milk,36100,-0.0625325829734901,0.0553552085363385,-0.171028791704714,0.0459636257577334,0.258658666541376
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20723.Liking for smoked fish,36100,0.113525302471872,0.0532031250449943,0.00924717738368354,0.217803427560061,0.0328936034423071
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20724.Liking for soft cheese,36100,0.0203519402524626,0.0541596659828387,-0.0858010050739012,0.126504885578826,0.707094472230212
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20725.Liking for soy sauce,36100,-0.0774666243641813,0.0540068120359276,-0.183319975954599,0.0283867272262368,0.151507429384979
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20726.Liking for soya milk,36100,-0.0689453130764176,0.0553867730455173,-0.177503388245632,0.0396127620927963,0.213248513581017
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20727.Liking for spicy foods,36100,-0.127714496296859,0.0535260104414057,-0.232625476762015,-0.0228035158317042,0.0170583250637965
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20728.Liking for spinach,36100,-0.0483001497203675,0.0523221882104679,-0.150851638612885,0.0542513391721495,0.355972072437388
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20729.Liking for spirits,36100,0.0483742074508432,0.0517649994744625,-0.0530851915191033,0.14983360642079,0.350080589835341
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20730.Liking for strawberries,36100,0.0740135955203203,0.0593561593985619,-0.0423244769008611,0.190351667941502,0.212461680223175
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36100,-0.0362986480932316,0.0568406822861498,-0.147706385374085,0.075109089187622,0.523102229261718
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20732.Liking for sweet foods,36100,-0.0550754688557231,0.0511053568085207,-0.155241968200424,0.0450910304889775,0.28121211190394
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20733.Liking for taking the stairs,36100,-0.121390849386934,0.0542388374690379,-0.227698970826249,-0.01508272794762,0.0252476376447965
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20734.Liking for tea with sugar,36100,-0.031808580194067,0.0682173591753018,-0.165514604177659,0.101897443789525,0.641027825797823
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20735.Liking for tea without sugar,36100,-0.0532652364843695,0.0550521172904253,-0.161167386373603,0.054636913404864,0.333307074234929
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20736.Liking for tomato ketchup,36100,-0.0560149783422575,0.0555250200334953,-0.164844017607908,0.0528140609233934,0.313094391425789
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20737.Liking for tinned tuna,36100,-0.000264510136760539,0.0509552991600447,-0.100136896490448,0.099607876216927,0.99585833151884
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20738.Liking for turnip (white),36100,-0.0247464045780375,0.0525639454690761,-0.127771737697427,0.0782789285413515,0.637807976748785
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20739.Liking for vegetables,36100,-0.00241174838293715,0.0591647150038531,-0.118374589790489,0.113551093024615,0.967485785953168
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20740.Liking for vinegar,36100,0.054112586422058,0.0518081091583947,-0.0474313075283956,0.155656480372512,0.296299504393609
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20741.Liking for watching television,36100,0.0498801869825581,0.0519208690179458,-0.0518847162926155,0.151645090257732,0.336738567685092
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20742.Liking for whisky,36100,0.0542276996658807,0.0550462499821693,-0.0536629502991711,0.162118349630933,0.324594888016166
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20743.Liking for white bread,36100,0.0446630617500453,0.0545452876146918,-0.0622457019747506,0.151571825474841,0.412914382234577
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20744.Liking for white rice,36100,0.0120820597938855,0.0517813481222383,-0.0894093825257014,0.113573502113473,0.815513321189064
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20745.Liking for white wine,36100,0.0313962935157794,0.0525455495383476,-0.0715929835793819,0.134385570610941,0.550189060930331
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36100,-0.00757379201317476,0.0565429469257394,-0.118397967987624,0.103250383961274,0.893447918563937
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20747.Liking for whole milk,36100,0.0619853053072029,0.0527312719502328,-0.0413679877152535,0.165338598329659,0.239837625441569
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20748.Liking for wholemeal bread,36100,-0.0264774002769,0.0529698661517205,-0.130298337934272,0.0773435373804721,0.617191161172605
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20749.Liking for working up a sweat,36100,-0.154228786777839,0.0537816028643808,-0.259640728392025,-0.0488168451636526,0.00414738615913992
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X21001.Body mass index (BMI),51733,-0.00863552522118801,0.0122221858956124,-0.0325910095765882,0.0153199591342122,0.479856537014386
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X21002.Weight,51752,0.00176898650539785,0.00654795000559363,-0.0110649955055657,0.0146029685163614,0.787040536497946
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X21021.Pulse wave Arterial Stiffness index,36896,0.00517309355956672,0.00437392813977648,-0.00339980559439517,0.0137459927135286,0.236960153614376
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,35928,0.110009285559623,0.0527238919580708,0.00667045732180395,0.213348113797442,0.0369693921336394
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,35945,-0.0503540950896072,0.0555486572079075,-0.159229463217106,0.0585212730378915,0.364710895442077
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,35947,-0.0860182712078777,0.0556108836167924,-0.195015603096791,0.0229790606810354,0.121961151590359
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21040.Satisfaction with bowel habits,35901,0.0578390300969409,0.0493196855131481,-0.0388275535088293,0.154505613702711,0.240942912618523
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,35882,0.0343441917869151,0.0544126464234765,-0.0723045952030988,0.140992978776929,0.527944224596871
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21042.Greatest number of times bowels opened per day,35902,-0.0630951794955461,0.0546822782470033,-0.170272444859673,0.0440820858685804,0.248602539787049
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21043.Least number of times bowels opened per week,35837,-0.0456632924220257,0.0536299921284534,-0.150778076993794,0.059451492149743,0.394549754142675
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21044.Average number of times bowels opened per day,35866,-0.0733308295099827,0.065528554668061,-0.201766796659382,0.0551051376394168,0.26315197970579
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,35951,-0.0477598151284566,0.0570197149449059,-0.159518456420472,0.0639988261635591,0.402284018125388
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,35946,-0.0261565542453535,0.0586848456722783,-0.141178851763019,0.088865743272312,0.655819411812246
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32736,0.223373385025993,0.12013341948693,-0.0120881171683891,0.458834887220375,0.0630565243655366
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,35949,0.0296960982039768,0.0660545216626234,-0.0997707642547651,0.159162960662719,0.653035311720537
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,35948,-0.000562360202001166,0.0851557983445797,-0.167467724957377,0.166343004553375,0.994731085152223
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,35946,-0.0391105493817941,0.0637735771010352,-0.164106760499823,0.085885661736235,0.539717162264693
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,35946,-0.0223769061117426,0.161608119437752,-0.339128820209736,0.294375007986251,0.889877851747968
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,35952,-0.087575847501786,0.0636280347578784,-0.212286795627228,0.0371351006236556,0.168752090177933
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,35949,-0.0754413342958103,0.0610257979624391,-0.195051898302191,0.0441692297105702,0.216419651938074
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,35796,-0.0641347806690185,0.0601553109303524,-0.182039190092509,0.0537696287544722,0.286393367049562
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,35942,-0.0476153000075606,0.05610847280433,-0.157587906704047,0.0623573066889262,0.396117644891056
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,35948,-0.150646640884329,0.0770493555900884,-0.301663377840902,0.000370096072243975,0.0506010550216755
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,35953,-0.0551280843011922,0.0555981402153658,-0.164100439123309,0.0538442705209247,0.321454798772053
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,35952,0.0639415331190666,0.0575245775318537,-0.0488066388433666,0.1766897050815,0.266370563640451
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X21100.Water hardness (USGS classification),51698,-0.012818474302693,0.0321970326673641,-0.0759246583307267,0.0502877097253407,0.690541121901236
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2139.Age first had sexual intercourse,47976,0.00472569614371905,0.00307063255733587,-0.00129274366865925,0.0107441359560974,0.123821727463027
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2149.Lifetime number of sexual partners,46792,0.00835570121241149,0.0358842820524095,-0.0619774916103111,0.0786888940351341,0.815879595211787
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22032.IPAQ activity group,46823,-0.00900766689149879,0.03615004134484,-0.0798617479273852,0.0618464141443877,0.803228740484197
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22033.Summed days activity,47317,0.00187593868811535,0.00293869010819788,-0.00388389392395249,0.00763577130018318,0.523248210738875
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22034.Summed minutes activity,46823,0.000659353004377235,0.00292837985194516,-0.00508027150543527,0.00639897751418974,0.82185768212556
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22037.MET minutes per week for walking,45863,-0.00098100729186872,0.00313823141400587,-0.00713194086332022,0.00516992627958278,0.754589420293058
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22038.MET minutes per week for moderate activity,46823,0.00149071171016205,0.00285913283846112,-0.00411318865322174,0.00709461207354585,0.602104481933416
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22039.MET minutes per week for vigorous activity,46823,0.0181832408762151,0.0364479835478525,-0.0532548068775758,0.0896212886300061,0.617868780224805
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22040.Summed MET minutes per week for all activity,45863,0.00132167795300473,0.00304651098595973,-0.00464948357947634,0.00729283948548581,0.664415103546983
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X2217.Age started wearing glasses or contact lenses,49907,-0.00221922503108898,0.00245667589675416,-0.00703430978872714,0.00259585972654918,0.366353510903812
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X22501.Year ended full time education,34036,-0.00870396658705982,0.0136609508770155,-0.0354794303060103,0.0180714971318906,0.524062427053267
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X22506.Tobacco smoking,34005,0.0639127341081894,0.131530928068991,-0.193887884907032,0.321713353123411,0.627050201456328
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50545,-0.0233581003493998,0.12454887336025,-0.26747389213549,0.22075769143669,0.851237758609306
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23098.Weight,51269,0.00338340913269683,0.00663449608377229,-0.00962020319149685,0.0163870214568905,0.610075976601421
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23099.Body fat percentage,51263,0.00922313408576826,0.00630642718363478,-0.00313746319415591,0.0215837313656924,0.143619164758287
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23100.Whole body fat mass,51250,0.00583742662157734,0.00621578695084335,-0.00634551580207562,0.0180203690452303,0.347674731500838
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23101.Whole body fat-free mass,51268,-0.00133376374684409,0.00541160753781933,-0.01194051452097,0.0092729870272818,0.80532574585511
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23102.Whole body water mass,51269,-0.00137076429381256,0.005427182678759,-0.0120080423441802,0.00926651375655508,0.800599909768077
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23104.Body mass index (BMI),51269,-0.00858598521763258,0.0122611709590476,-0.0326178802973658,0.0154459098621007,0.483773465559706
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23105.Basal metabolic rate,51269,-0.00104723816741637,0.00577825450664084,-0.0123726170004324,0.0102781406655997,0.856182585206157
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23106.Impedance of whole body,51267,0.00698467758028598,0.00440846436544519,-0.0016559125759866,0.0156252677365586,0.113121864005891
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23107.Impedance of leg (right),51269,0.00482857209892591,0.00356647804884491,-0.00216172487681011,0.0118188690746619,0.175789527666776
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23108.Impedance of leg (left),51269,0.00293871058305313,0.00354308328439148,-0.00400573265435417,0.00988315382046044,0.406874727745657
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23109.Impedance of arm (right),51266,0.00865610963468574,0.00435080001819925,0.000128541599015222,0.0171836776703563,0.0466534703769537
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23110.Impedance of arm (left),51269,0.00752833320567393,0.00436816369492178,-0.00103326763637275,0.0160899340477206,0.0848202935168243
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23111.Leg fat percentage (right),51269,0.0087896935782568,0.00743562001953464,-0.00578412166003109,0.0233635088165447,0.237176241469448
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23112.Leg fat mass (right),51269,0.00971355983678394,0.00814244346072996,-0.00624562934624679,0.0256727490198147,0.232900242331597
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23113.Leg fat-free mass (right),51268,-0.00287274244143325,0.00550330774163228,-0.0136592256150325,0.00791374073216601,0.601673569429361
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23114.Leg predicted mass (right),51268,-0.00332010827607753,0.00553696225261776,-0.0141725542912083,0.00753233773905328,0.548761459527478
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23115.Leg fat percentage (left),51266,0.00556567099446599,0.00781591695453741,-0.00975352623642732,0.0208848682253593,0.476413824573858
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23116.Leg fat mass (left),51266,0.00656971294549577,0.00852052490568723,-0.0101305158696512,0.0232699417606427,0.440688177463213
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23117.Leg fat-free mass (left),51265,-0.000898660344701032,0.00579450510471526,-0.0122558903499429,0.0104585696605409,0.876753069781034
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23118.Leg predicted mass (left),51265,-0.000954774205161894,0.00583088350107685,-0.0123833058672725,0.0104737574569487,0.869933904966177
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23119.Arm fat percentage (right),51265,0.0107093764635025,0.00712084319727662,-0.00324747620315972,0.0246662291301646,0.132609116358446
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23120.Arm fat mass (right),51263,0.00393063264641807,0.00710188589296643,-0.00998906370379614,0.0178503289966323,0.579951864780361
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23121.Arm fat-free mass (right),51264,-0.00299800290834831,0.00552487310617866,-0.0138267541964585,0.00783074837976185,0.587384946214282
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23122.Arm predicted mass (right),51264,-0.00450289647354216,0.005536100651198,-0.0153536537498902,0.00634786080280592,0.41601490602276
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23123.Arm fat percentage (left),51263,0.0112893132606808,0.00728953008136107,-0.00299816569878687,0.0255767922201485,0.121467598396332
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23124.Arm fat mass (left),51263,0.00307884213897563,0.00711018275811028,-0.0108571160669205,0.0170148003448718,0.665005411818099
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23125.Arm fat-free mass (left),51263,-0.00267688025711049,0.00563898447714682,-0.0137292898323183,0.00837552931809729,0.634998647525421
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23126.Arm predicted mass (left),51261,-0.00262465900702721,0.00564053767477691,-0.01368011284959,0.00843079483553552,0.641706396449731
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23127.Trunk fat percentage,51260,0.00574126074494732,0.00451129092209355,-0.00310086946235604,0.0145833909522507,0.203158324487545
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23128.Trunk fat mass,51260,0.00657380740799831,0.00504671825498891,-0.00331776037177996,0.0164653751877766,0.192728186730275
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23129.Trunk fat-free mass,51259,-0.000863865899304215,0.00488861303152466,-0.0104455474410925,0.00871781564248412,0.859737953610838
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23130.Trunk predicted mass,51256,-0.00118238932495211,0.00490260813573226,-0.0107915012709873,0.00842672262108311,0.809421283571573
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23400.Total Cholesterol,42346,0.00997075192923681,0.00356718089942164,0.0029790773663704,0.0169624264921032,0.00519532255315387
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42346,0.0107079014722151,0.0034618495771947,0.00392267630091351,0.0174931266435167,0.00198481792321573
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42346,0.00988445893924223,0.00345700452781452,0.00310873006472579,0.0166601878137587,0.00425304574674423
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23403.VLDL Cholesterol,42346,0.0101698965498564,0.00351628002048008,0.00327798770971549,0.0170618053899974,0.00383142882476764
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23404.Clinical LDL Cholesterol,42346,0.0105736317211396,0.00345911525513542,0.00379376582107416,0.017353497621205,0.00224203724543753
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23405.LDL Cholesterol,42346,0.0112250047693039,0.0034768680257766,0.00441034343878177,0.0180396660998261,0.00124754459755518
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23406.HDL Cholesterol,42346,0.000297665987220242,0.00398476672752097,-0.00751247679872086,0.00810780877316135,0.940453762505552
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23407.Total Triglycerides,42346,0.00714330209554125,0.00380575412633108,-0.000315975992067662,0.0146025801831502,0.0605437566960596
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23408.Triglycerides in VLDL,42346,0.00720618757089087,0.00378980352496576,-0.000221827338042028,0.0146342024798238,0.0572626607036949
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23409.Triglycerides in LDL,42346,0.00799249995087511,0.00377779500114711,0.000588021748626774,0.0153969781531234,0.0343931512014552
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23410.Triglycerides in HDL,42346,0.00287702269815056,0.00373198686094448,-0.00443767154930063,0.0101917169456017,0.440774650946376
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42346,0.00809957494551257,0.00369812715481653,0.000851245722072169,0.015347904168953,0.0285284701834293
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23412.Phospholipids in VLDL,42346,0.00947850143658113,0.00363182841545708,0.00236011774228525,0.016596885130877,0.00906864544252525
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23413.Phospholipids in LDL,42346,0.0109771849769419,0.00345607579803702,0.00420327641278933,0.0177510935410944,0.00149563077450153
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23414.Phospholipids in HDL,42346,-0.000835936611393532,0.00395770897324119,-0.00859304619894627,0.0069211729761592,0.832720982779235
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23415.Total Esterified Cholesterol,42346,0.00976304990098212,0.00358463007478326,0.00273717495440693,0.0167889248475573,0.00646625403554372
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42346,0.0101298762871029,0.00347414689394397,0.00332054837497267,0.016939204199233,0.00355390425788523
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42346,0.0114687211656318,0.00348145801301731,0.00464506346011792,0.0182923788711458,0.000989527341079845
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42346,6.74422715786214e-05,0.00396460196507082,-0.00770317757996019,0.00783806212311743,0.986428012313804
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23419.Total Free Cholesterol,42346,0.0103287078608999,0.00352718742650264,0.00341542050495477,0.0172419952168451,0.00341391575094452
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23420.Free Cholesterol in VLDL,42346,0.0100135817694302,0.00358868618456949,0.00297975684767398,0.0170474066911864,0.00527318399364766
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23421.Free Cholesterol in LDL,42346,0.0102237596344918,0.00348153743953238,0.00339994625300831,0.0170475730159752,0.00332444723331925
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23422.Free Cholesterol in HDL,42346,0.00107750412920345,0.00402547074292046,-0.00681241852692064,0.00896742678532755,0.788956322136644
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42346,0.00967118200899138,0.0035627355095526,0.00268822041026828,0.0166541436077145,0.00664547762137834
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23424.Total Lipids in VLDL,42346,0.00903941236078925,0.00368162873355386,0.00182342004302369,0.0162554046785548,0.0140905193405619
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23425.Total Lipids in LDL,42346,0.0112145673873931,0.00347459020827973,0.00440437057916479,0.0180247641956213,0.00125141780517551
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23426.Total Lipids in HDL,42346,-0.000192441489961707,0.00397941103148074,-0.00799208711166396,0.00760720413174054,0.961430637919361
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42346,0.00521264132910811,0.00375481457849419,-0.00214679524474049,0.0125720779029567,0.165082824342928
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23428.Concentration of VLDL Particles,42346,0.0100934633857469,0.00358329232152691,0.00307021043555412,0.0171167163359396,0.00485750643773472
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23429.Concentration of LDL Particles,42346,0.0113469327770217,0.00344563398164244,0.00459349017300248,0.0181003753810408,0.000993389043338265
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23430.Concentration of HDL Particles,42346,0.00339961306461319,0.00376169997984731,-0.00397331889588753,0.0107725450251139,0.366147816483482
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42346,0.00557377109708642,0.00385496015109028,-0.00198195079905052,0.0131294929932234,0.148237505812636
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23432.Average Diameter for LDL Particles,42346,0.00413870922662217,0.0036767223666414,-0.00306766661199497,0.0113450850652393,0.260333464646059
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23433.Average Diameter for HDL Particles,42346,-0.00433865003240031,0.00412438166175305,-0.0124224380894363,0.00374513802463565,0.292841066918436
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23434.Phosphoglycerides,42335,0.0061833499612693,0.00377108156422113,-0.0012079699046041,0.0135746698271427,0.101096596546761
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42335,0.00481231426734105,0.00395437621235101,-0.00293826310886692,0.012562891643549,0.223641618142631
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23436.Total Cholines,42335,0.00682916555418307,0.00377460461425092,-0.00056905948974873,0.0142273905981149,0.0704365711951535
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23437.Phosphatidylcholines,42335,0.00638241864057073,0.00380475532580533,-0.00107490179800771,0.0138397390791492,0.0934715310274557
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23438.Sphingomyelins,42335,0.00885727538643463,0.00370498406710559,0.00159550661490767,0.0161190441579616,0.0168331220769598
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23439.Apolipoprotein B,42346,0.0108755251973084,0.00344353089901408,0.00412620463524078,0.017624845759376,0.00159079340106266
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23440.Apolipoprotein A1,42346,0.00080907306651044,0.0038840637843106,-0.00680369195073834,0.00842183808375922,0.834993418244009
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42346,0.00948239009143353,0.00352703721123039,0.00256939715742196,0.0163953830254451,0.00718672728300774
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23442.Total Fatty Acids,42335,0.00744366946006905,0.00367237846040365,0.000245807677677886,0.0146415312424602,0.04268929261241
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23443.Degree of Unsaturation,42335,0.00489075333224693,0.00373545971772074,-0.00243074771448573,0.0122122543789796,0.190463262835695
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23444.Omega-3 Fatty Acids,42335,0.010357892409091,0.00370880895539061,0.00308862685652539,0.0176271579616566,0.00523325544635113
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23445.Omega-6 Fatty Acids,42335,0.00741439795803615,0.00361476285747104,0.000329462757392904,0.0144993331586794,0.0402727404728512
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42335,0.0090795709862233,0.00366776301106478,0.00189075548453634,0.0162683864879103,0.0133172459903864
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42335,0.0055546791729542,0.00376401139868433,-0.00182278316846709,0.0129321415143755,0.140039304486482
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23448.Saturated Fatty Acids,42335,0.00686771882125361,0.00367358881450992,-0.000332515255185828,0.0140679528976931,0.0615776043988331
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23449.Linoleic Acid,42335,0.00654850986072271,0.00354081890392782,-0.000391495190975821,0.0134885149124212,0.0644176510181921
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23450.Docosahexaenoic Acid,42335,0.00923587448224746,0.00370227277821858,0.00197941983693905,0.0164923291275559,0.012620327040043
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42335,0.00800100043471896,0.00366363054476459,0.000820284566980365,0.0151817163024575,0.0289872625147742
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42335,-0.00449895056712525,0.00394796848843309,-0.0122369688044541,0.00323906767020361,0.254490049197877
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42335,-0.000715581630016029,0.00389420055337915,-0.00834821471463916,0.0069170514546071,0.854207929305935
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42335,-0.000254115014059896,0.00394272398318431,-0.00798185402110115,0.00747362399298135,0.948611595607374
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42335,0.00113365922169035,0.00357488465964721,-0.00587311471121818,0.00814043315459887,0.751159328311357
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42335,-0.000728330091016745,0.00378616229652822,-0.00814920819221205,0.00669254801017856,0.847458248421432
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42335,0.00500317271075064,0.0036512317366545,-0.00215324149309217,0.0121595869145934,0.170626093419504
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42335,3.53311144381836e-05,0.00395216407750719,-0.0077109104774759,0.00778157270635227,0.99286739154131
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42335,-0.00783603238627254,0.00362611160175278,-0.014943211125708,-0.000728853646837091,0.0307132358099225
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23460.Alanine,42341,0.00843907785836343,0.00357518573747047,0.00143171381292131,0.0154464419038056,0.0182668739505466
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23461.Glutamine,42303,0.00295973497645484,0.00359115365607721,-0.00407892618945648,0.00999839614236617,0.409855771418619
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23462.Glycine,42330,0.00041531410765446,0.00381120347070688,-0.00705464469493102,0.00788527291023994,0.913226437570883
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23463.Histidine,42327,0.0046435201121729,0.00352400360748423,-0.00226352695849619,0.011550567182842,0.187632728684848
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42337,-0.000571808508867224,0.00373503372857983,-0.00789247461688368,0.00674885759914924,0.878327077145908
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23465.Isoleucine,42342,0.000851472123702998,0.00363377259275951,-0.00627072215810565,0.00797366640551164,0.814738813923163
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23466.Leucine,42342,-0.00140865630389363,0.00367527499124716,-0.00861219528673807,0.00579488267895081,0.701518987723465
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23467.Valine,42337,-0.00058453853837932,0.003776445735501,-0.00798637217996129,0.00681729510320265,0.876992904560649
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23468.Phenylalanine,42339,-0.000431914283710399,0.00356508560711279,-0.00741948207365146,0.00655565350623066,0.903573153526585
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23469.Tyrosine,42330,0.000992538084390429,0.00362993698843197,-0.00612213841293624,0.0081072145817171,0.784526058598159
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23470.Glucose,42319,0.00178709345229347,0.00352482951228653,-0.00512157239178814,0.00869575929637507,0.612162362900468
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23471.Lactate,42321,0.00177662609806961,0.00354190125767219,-0.00516550036696788,0.00871875256310711,0.61595565745345
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23472.Pyruvate,42306,0.00525457427187263,0.00357808335150155,-0.0017584690970704,0.0122676176408157,0.141980393561096
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23473.Citrate,42343,-0.00238895827852742,0.00357986609456911,-0.00940549582388287,0.00462757926682802,0.504571965904179
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23474.3-Hydroxybutyrate,42130,-0.00466168352914893,0.0037642958148049,-0.0120397033261665,0.00271633626786868,0.215592262325334
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23475.Acetate,42335,0.00275510686064197,0.00352253765988031,-0.00414906695272344,0.00965928067400739,0.434148186117451
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23476.Acetoacetate,42344,-0.00682500777664275,0.00361183089972646,-0.0139041963401066,0.000254180786821122,0.058830040323713
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23477.Acetone,42344,-0.00356638475103993,0.00358014009535668,-0.010583459337939,0.00345068983585916,0.319191772785833
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23478.Creatinine,42039,-0.00192356674905859,0.00402264341454518,-0.00980794784156715,0.00596081434344997,0.632526851228085
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23479.Albumin,42344,0.0067914135659588,0.00358446838653238,-0.000234144471644664,0.0138169716035623,0.0581569844604719
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23480.Glycoprotein Acetyls,42346,0.00313458085959799,0.00379377402933893,-0.0043012162379063,0.0105703779571023,0.408681005681581
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42346,0.00375296834622402,0.00381838838863096,-0.00373107289549266,0.0112370095879407,0.325690928742584
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42346,0.00262744631163716,0.00377428894628408,-0.00477016002307964,0.010025052646354,0.48635133567004
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42346,0.00324009547406406,0.00382771281888041,-0.00426222165094154,0.0107424125990697,0.397298515350553
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42346,0.00357211896644117,0.00379029067947823,-0.00385685076533616,0.0110010886982185,0.345985075347455
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42346,0.00510353311237454,0.00374526503719864,-0.00223718636053479,0.0124442525852839,0.173012157915435
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42346,0.00267093060487418,0.00382716927902464,-0.00483032118201412,0.0101721823917625,0.485260379344394
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42346,0.00277439761222775,0.00373906611491889,-0.00455417197301328,0.0101029671974688,0.45809887550508
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42346,0.00717421529590339,0.00380478528687364,-0.000283163866368951,0.0146315944581757,0.0593740111387077
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42346,0.00714871151100821,0.003785319402458,-0.000270514517809465,0.0145679375398259,0.0589760314467078
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42346,0.00737958756726296,0.00377309535350334,-1.5679325603579e-05,0.0147748544601295,0.0505046219220976
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42346,0.00892408621927612,0.00368469168094368,0.0017020905246265,0.0161460819139257,0.0154515129725639
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42346,0.00988154435720853,0.00362471185497262,0.00277710912146219,0.0169859795929549,0.00641607892815249
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42346,0.00756508127599686,0.00374484242399615,0.000225190124964411,0.0149049724270293,0.043389784929437
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42346,0.00633702788523253,0.00380813416917036,-0.00112691508634138,0.0138009708568064,0.0961208967213031
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42346,0.00835610940561127,0.00375865184455761,0.00098915179027835,0.0157230670209442,0.026221493787021
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23496.Total Lipids in Large VLDL,42346,0.00874077367751827,0.00373692664292041,0.00141639745739427,0.0160651498976423,0.0193489084623685
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23497.Phospholipids in Large VLDL,42346,0.00818306152069482,0.00375635661098022,0.000820602563173601,0.015545520478216,0.029389723965267
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23498.Cholesterol in Large VLDL,42346,0.00959897902486632,0.00367921166724041,0.00238772415707512,0.0168102338926575,0.00909160857983453
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42346,0.00999557847881622,0.00361332665090078,0.00291345824305068,0.0170776987145817,0.00567738974121282
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42346,0.00895591841558783,0.00374802280291684,0.00160979372187082,0.0163020431093048,0.016885103581159
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23501.Triglycerides in Large VLDL,42346,0.00828336743860872,0.00373316625106377,0.000966361586523737,0.0156003732906937,0.0265133601060541
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42346,0.0110968313810854,0.00351890549903534,0.00419977660297614,0.0179938861591947,0.0016169391222332
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42346,0.0111900927082157,0.00355972258504935,0.00421303644151895,0.0181671489749124,0.00167294718521734
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42346,0.0110578888047559,0.00350395633459861,0.00419013438894263,0.0179256432205692,0.00160403318709159
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42346,0.0106029801230269,0.00343851070132917,0.00386349914842173,0.0173424610976321,0.00204938280457292
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42346,0.0100341987464339,0.00344912903268469,0.00327390584237194,0.0167944916504959,0.00362964322247701
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42346,0.0111921838083795,0.00347780099145742,0.00437569386512295,0.018008673751636,0.00129320283142292
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42346,0.00958973223914494,0.00370126433245699,0.00233525414752924,0.0168442103307606,0.00958214722689277
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42346,0.0102683181964015,0.00364022673176787,0.00313347380213652,0.0174031625906666,0.00479771673755077
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23510.Total Lipids in Small VLDL,42346,0.01047047467714,0.00362924959412508,0.00335714547265483,0.0175838038816252,0.00392018872494262
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23511.Phospholipids in Small VLDL,42346,0.0113197474829493,0.00353897193089448,0.00438336249839609,0.0182561324675025,0.00138425014877567
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23512.Cholesterol in Small VLDL,42346,0.0110815736515707,0.00350380028123333,0.0042141251003534,0.017949022202788,0.00156652650472397
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42346,0.0107389601674143,0.00352288844126806,0.00383409882252888,0.0176438215122997,0.00230566728681708
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42346,0.0113656995395645,0.00347613833191143,0.00455246840901811,0.0181789306701109,0.0010796355977005
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23515.Triglycerides in Small VLDL,42346,0.0075224868775507,0.00377339185994268,0.000126638832063044,0.0149183349230383,0.0462206687643884
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42346,0.00842874429783759,0.00354110418230587,0.00148818010051808,0.0153693084951571,0.0173146465161754
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42346,0.00840993736308438,0.00357594622868197,0.00140108275486771,0.0154187919713011,0.0186971028072736
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42346,0.00825355529713521,0.0035806164037204,0.00123554714584324,0.0152715634484272,0.0211783978898576
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42346,0.00810850269269429,0.00352305818036144,0.00120330865918587,0.0150136967262027,0.0213759861598391
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42346,0.00784996858806647,0.00352586655435391,0.00093927014153281,0.0147606670346001,0.0260046661370667
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42346,0.00866092383819504,0.00354635793598722,0.00171006228366008,0.01561178539273,0.0146110361761101
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42346,0.0067096081762432,0.00377332570438617,-0.000686110204353693,0.0141053265568401,0.0753993137900643
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23523.Concentration of IDL Particles,42346,0.00827635326618838,0.00342414917057666,0.00156502089185812,0.0149876856405186,0.0156602133123292
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23524.Total Lipids in IDL,42346,0.00884494921476207,0.00352530422808573,0.00193535292771403,0.0157545455018101,0.0121196560177989
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23525.Phospholipids in IDL,42346,0.00947358867769233,0.00353450008448503,0.00254596851210166,0.016401208843283,0.00736436258892694
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23526.Cholesterol in IDL,42346,0.00840170435948163,0.00352264400583197,0.00149732210805097,0.0153060866109123,0.0170905845110795
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42346,0.00848618473936397,0.003525291946517,0.00157661252419066,0.0153957569545373,0.0160877780688213
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23528.Free Cholesterol in IDL,42346,0.0081316027097278,0.00351325310437795,0.00124562662514702,0.0150175787943086,0.0206528534252311
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23529.Triglycerides in IDL,42346,0.00685375359972865,0.00377298634019555,-0.00054129962705463,0.0142488068265119,0.0693114279330918
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23530.Concentration of Large LDL Particles,42346,0.0112364177717798,0.00344674317501861,0.00448080114874333,0.0179920343948163,0.00111691464330554
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23531.Total Lipids in Large LDL,42346,0.0109073560574614,0.00349429748639936,0.00405853298411868,0.0177561791308042,0.00180338430340981
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23532.Phospholipids in Large LDL,42346,0.0104256355028409,0.00346763236411443,0.00362907606917662,0.0172221949365052,0.0026472311554025
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23533.Cholesterol in Large LDL,42346,0.0109166188810484,0.00350135123935033,0.00405397045192171,0.017779267310175,0.0018258067387068
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42346,0.0112752760137514,0.00350182615920373,0.00441169674171207,0.0181388552857907,0.00128579273108526
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42346,0.00985050377799121,0.00350580606797022,0.00297912388476957,0.0167218836712128,0.00496503330039339
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23536.Triglycerides in Large LDL,42346,0.00781694749074833,0.00376920657883334,0.000429302596234982,0.0152045923852617,0.0381082595722447
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42346,0.0111082666606072,0.00346510046244182,0.00431666975422126,0.0178998635669932,0.00135030047978325
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23538.Total Lipids in Medium LDL,42346,0.0116234024973566,0.00348589544781473,0.00479104741963973,0.0184557575750735,0.000857170156011838
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23539.Phospholipids in Medium LDL,42346,0.0115342558072817,0.00347929330332091,0.00471484093277276,0.0183536706817907,0.000918533893425452
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23540.Cholesterol in Medium LDL,42346,0.0115725821544111,0.00347787069911709,0.00475595558414159,0.0183892087246806,0.000878722927168376
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42346,0.0116314736777639,0.0034959142049205,0.00477948183611967,0.018483465519408,0.000879758331782461
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42346,0.0108663120355497,0.003468497694515,0.00406805655430034,0.0176645675167991,0.00173493018359154
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23543.Triglycerides in Medium LDL,42346,0.00829259665224961,0.00378406760076756,0.000875824154745193,0.015709369149754,0.028436686939392
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23544.Concentration of Small LDL Particles,42346,0.010478859537573,0.0034466192468056,0.00372348581383399,0.0172342332613119,0.00236783945056664
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23545.Total Lipids in Small LDL,42346,0.0113567720305066,0.00345168342698127,0.00459147251362332,0.0181220715473899,0.00100375097264726
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23546.Phospholipids in Small LDL,42346,0.0110364253786331,0.00342712929091099,0.0043192519684476,0.0177535987888187,0.00128362322386221
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23547.Cholesterol in Small LDL,42346,0.0113439428701578,0.00345049737585875,0.0045809680134746,0.0181069177268409,0.00101301190867437
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42346,0.0113991371428324,0.00347079109690882,0.00459638659289107,0.0182018876927736,0.00102501313658479
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42346,0.0103226806141467,0.00344423012619723,0.00357198956680012,0.0170733716614933,0.00273075620916253
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23550.Triglycerides in Small LDL,42346,0.00737507000173862,0.00380470651203753,-8.21547618549343e-05,0.0148322947653322,0.0525949484548655
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42346,0.000585829620075898,0.0039546625539026,-0.0071653089855732,0.008336968225725,0.882237365086162
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42346,-0.000857932214902748,0.00397571091849311,-0.00865032561514924,0.00693446118534374,0.829152132027248
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42346,-0.00175042448145455,0.00400170963182343,-0.00959377535982846,0.00609292639691937,0.66181457085443
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42346,-2.24806737229207e-05,0.00393357095816661,-0.00773227975172948,0.00768731840428364,0.995440137201012
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42346,0.000125798797365987,0.00397317923098333,-0.00766163249536134,0.00791323009009332,0.974742080421806
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42346,0.000100851523700159,0.00376463077893735,-0.00727782480301704,0.00747952785041736,0.978628257443605
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42346,0.00485339031504789,0.00370936110327624,-0.00241695744737354,0.0121237380774693,0.190754848341417
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23558.Concentration of Large HDL Particles,42346,-0.00157905500844247,0.00412483295359514,-0.00966372759748893,0.006505617580604,0.7018618522915
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23559.Total Lipids in Large HDL,42346,-0.00231535466859289,0.00413109512008135,-0.0104123011039523,0.00578159176676655,0.575168478934839
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23560.Phospholipids in Large HDL,42346,-0.00288822737510249,0.00412705955782581,-0.0109772641084411,0.0052008093582361,0.484047779072728
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23561.Cholesterol in Large HDL,42346,-0.0018079461264134,0.00408930176310432,-0.00982297758209787,0.00620708532927107,0.658412467806173
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42346,-0.00173407997382644,0.00408196491327316,-0.00973473120384183,0.00626657125618896,0.670978482680423
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42346,-0.00186234024583565,0.00409687565915371,-0.00989221653777693,0.00616753604610563,0.649422000384845
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23564.Triglycerides in Large HDL,42346,0.000753731241694038,0.00382938847436872,-0.00675187016806865,0.00825933265145672,0.843965105212397
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42346,-0.000491136447419415,0.00385257950443542,-0.00804219227611283,0.007059919381274,0.898560476078105
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23566.Total Lipids in Medium HDL,42346,-0.000639765131918967,0.00382182538438771,-0.00813054288531888,0.00685101262148094,0.867059635814022
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23567.Phospholipids in Medium HDL,42346,-0.00101539069267131,0.00380323906436174,-0.00846973925882032,0.0064389578734777,0.789488355760928
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23568.Cholesterol in Medium HDL,42346,-0.000553994749290388,0.00384241957399841,-0.00808513711432727,0.0069771476157465,0.885361632842253
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42346,-0.000766006754487566,0.0038231311897056,-0.00825934388631054,0.0067273303773354,0.84120128153659
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42346,0.00036095408750486,0.00390869116219436,-0.00730008059039609,0.00802198876540581,0.926424122752846
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23571.Triglycerides in Medium HDL,42346,0.00185300469364217,0.00371496409943907,-0.0054283249412584,0.00913433432854274,0.617932308697461
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23572.Concentration of Small HDL Particles,42346,0.00640218629914186,0.00354219388172156,-0.000540513709032396,0.0133448863073161,0.0707216702062042
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23573.Total Lipids in Small HDL,42346,0.00488760129123927,0.00356984618511649,-0.00210929723158906,0.0118844998140676,0.170980465243904
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23574.Phospholipids in Small HDL,42346,0.00374133098602482,0.00359132652083807,-0.0032976689948178,0.0107803309668674,0.297538152360438
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23575.Cholesterol in Small HDL,42346,0.00605389654546,0.00353896023167788,-0.000882465508628652,0.0129902585995486,0.0871706709008049
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42346,0.00537677156885075,0.00352154179268671,-0.0015254503448152,0.0122789934825167,0.126829037742618
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42346,0.00721135859875073,0.00362724561322726,0.000101957196825297,0.0143207600006762,0.0468203640816054
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23578.Triglycerides in Small HDL,42346,0.00471631484289225,0.00378263276831123,-0.00269764538299775,0.0121302750687823,0.212480604359891
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41861,-0.00254746920138829,0.00365974082963906,-0.00972056122748086,0.00462562282470427,0.486392048809849
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41861,0.00311135617409194,0.00377317441762965,-0.00428406568446218,0.0105067780326461,0.4096147678533
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41861,0.00556497909791393,0.00373374280619822,-0.00175315680223458,0.0128831149980624,0.136129295769863
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41861,-0.00135871624219371,0.00379022149250703,-0.00878755036750749,0.00607011788312007,0.719990572000782
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41861,-0.00130033175107675,0.00374114325871425,-0.00863297253815669,0.00603230903600319,0.728164379479076
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42229,0.00321024988509992,0.00362150297486006,-0.0038878959456258,0.0103083957158256,0.375396113902449
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42229,0.000701871391086627,0.00379844670031418,-0.00674308414152917,0.00814682692370242,0.853405624417611
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42229,0.00119508108049179,0.0038037346941549,-0.0062602389200518,0.00865040108103539,0.75338462508948
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42229,-3.87739753490191e-05,0.00374436285526046,-0.00737772517165952,0.00730017722096148,0.991737977537609
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42229,-0.00170368015946462,0.00372290001565484,-0.0090005641901481,0.00559320387121886,0.647231815117534
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42345,0.00256248123215373,0.00369174006703618,-0.00467332929923717,0.00979829176354464,0.487624208651486
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42345,0.00151002238209407,0.00357701307679435,-0.00550092324842285,0.008520968012611,0.672925228207711
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42345,0.000923817495084097,0.00368413686608831,-0.006297090762449,0.00814472575261719,0.802007083955058
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42345,0.00160511868901673,0.00353660216257572,-0.00532662154963168,0.00853685892766513,0.649937810946401
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42345,-0.00230779742948135,0.00351997348305224,-0.00920694545626374,0.00459135059730105,0.512074196262126
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42346,0.00365764369799593,0.00357575406464419,-0.00335083426870667,0.0106661216646985,0.306373300143341
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42346,0.00187715704836622,0.00371722107714538,-0.00540859626283874,0.00916291035957117,0.613574778854731
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42346,0.00141117901566314,0.00375727743072936,-0.00595308474856641,0.00877544277989269,0.707231110905877
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42346,0.0033528765218303,0.00362439859652038,-0.00375094472734965,0.0104566977710102,0.354938704338537
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42346,-0.00227711405880094,0.0036824823326324,-0.00949477943076044,0.00494055131315856,0.536346211001645
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42346,0.00411067070411375,0.00370954057091402,-0.00316002881487773,0.0113813702231052,0.26782390231612
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42346,0.00423901094109552,0.00361034882191632,-0.00283727274986046,0.0113152946320515,0.240365097164463
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42346,0.00405854465701957,0.00353757502087405,-0.00287510238389356,0.0109921916979327,0.251291973698076
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42346,0.00407617511229501,0.00372448449399299,-0.00322381449593124,0.0113761647205213,0.273787940832941
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42346,-0.00426514992777382,0.00364372028098568,-0.0114068416785058,0.00287654182295812,0.241801669841196
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42346,-0.000496366930909591,0.00362529289520082,-0.0076019410055032,0.00660920714368402,0.891097907601122
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42346,0.00165307670621681,0.00375499185568366,-0.00570670733092316,0.00901286074335679,0.659774558810925
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42346,0.00120462805441127,0.00378662940422509,-0.0062171655778699,0.00862642168669244,0.750393854566044
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42346,0.00454324890420903,0.00355262957396899,-0.0024199050607702,0.0115064028691883,0.200975562522999
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42346,-0.00160976128690358,0.00373991691784119,-0.00893999844587232,0.00572047587206515,0.666892098053511
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42346,0.000488470247782144,0.00341788854517678,-0.00621059130076435,0.00718753179632864,0.886358875857771
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42346,0.00166585805452053,0.00361940168190198,-0.00542816924200735,0.00875988535104841,0.645338757186426
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42346,0.00198653617419403,0.00361679818647427,-0.00510238827129554,0.00907546061968359,0.582841366861026
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42346,0.000107129660955871,0.00347475579112989,-0.00670339168965871,0.00691765101157045,0.975404908311067
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42346,-0.00221339592470891,0.00373787111732953,-0.00953962331467479,0.00511283146525697,0.553757542793777
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42346,-0.00425155456128124,0.00346299428492504,-0.0110390233597343,0.00253591423717184,0.219577623162278
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42346,0.00686680416430812,0.0037571931335378,-0.000497294377425974,0.0142309027060422,0.0676259352612315
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42346,0.00979460949409122,0.00349756001070814,0.00293939187310327,0.0166498271150792,0.00511118543277002
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42346,-0.000642473132573625,0.00375265500811215,-0.00799767694847344,0.00671273068332619,0.864065245126908
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42346,-0.00392108371642337,0.00374756301237194,-0.0112663072206724,0.00342413978782562,0.295440722638888
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42346,-0.00341845234406824,0.00354780431951476,-0.0103721488103172,0.00353524412218068,0.33529417877908
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42346,0.00629151931099982,0.00345686738649046,-0.000483940766521493,0.0130669793885211,0.0687808141473854
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42346,0.0073349143918427,0.0035760403794092,0.000325875248200681,0.0143439535354847,0.0402743086709523
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42346,-0.00205539949678148,0.00383695420922403,-0.00957582974686058,0.00546503075329762,0.592185207699792
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42346,-0.00439352200010876,0.003680424446994,-0.011607153916217,0.00282010991599947,0.232595678377111
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42346,-0.0042593670922852,0.00351327419520951,-0.0111453845148958,0.00262665033032544,0.225394859643675
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42346,0.00501585256208116,0.00353390841431106,-0.00191060792996853,0.0119423130541308,0.155820729725613
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42346,0.00533499404057681,0.00351224578942491,-0.00154900770669601,0.0122189957878496,0.128794224159326
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42346,0.000430505376525018,0.00376228624442199,-0.00694357566254207,0.00780458641559211,0.908901427389276
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42346,-0.00207765259906319,0.00375961642755393,-0.00944650079706889,0.00529119559894252,0.580530600103527
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42337,-0.00721880515073648,0.00391162318947277,-0.0148855866021031,0.000447976300630155,0.0649908632204904
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42337,0.00483092128107651,0.00369792642266866,-0.00241701450735407,0.0120788570695071,0.191444003518796
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42337,0.00295839638117629,0.00358470929883508,-0.00406763384454048,0.00998442660689305,0.409226436389474
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42337,0.00150916657569149,0.00408978091471963,-0.00650680401715898,0.00952513716854196,0.712126849420787
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42337,0.00451502777576998,0.00390571734590561,-0.00314017822220502,0.012170233773745,0.247700230118756
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42346,-0.0036031274314325,0.00380123726552256,-0.0110535524718567,0.00384729760899173,0.343206536530009
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42346,0.000436412981515317,0.00393037075285782,-0.00726711369408601,0.00813993965711665,0.91158942615615
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42346,-0.00020648445407407,0.00395623865035601,-0.00796071220877186,0.00754774330062372,0.958376410054568
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42346,0.00255364183892515,0.00372153730488431,-0.00474057127864809,0.0098478549564984,0.492612149532942
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42346,0.00234779982290582,0.00388452737946649,-0.0052658738408485,0.00996147348666014,0.545589620334672
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42346,-0.00232845305108154,0.00385861233453446,-0.00989133322676908,0.005234427124606,0.54622435316083
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42346,-0.000256885038115966,0.00382990527456351,-0.00776349937626045,0.00724972930002851,0.946524233412603
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42346,-0.00118019985434332,0.00380815626878333,-0.00864418614115865,0.00628378643247201,0.756631483517464
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42346,0.00368293897018528,0.00399878124731721,-0.00415467227455645,0.011520550214927,0.357059298374784
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42346,0.0019892520265629,0.00378109327001839,-0.00542169078267314,0.00940019483579894,0.598824134671822
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42346,-0.00797691545524391,0.00369595250875162,-0.0152209823723971,-0.000732848538090737,0.0309237899527084
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42346,0.00363573339024891,0.00369661392518541,-0.00360962990311449,0.0108810966836123,0.325364391169719
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42346,0.00151200305832293,0.00373218377196094,-0.00580307713472051,0.00882708325136638,0.685391804957329
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42346,0.0060733953904308,0.00368901512968683,-0.00115707426375539,0.013303865044617,0.0997164317599361
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42346,0.0026245113456055,0.00381785289418111,-0.00485848032698949,0.0101075030182005,0.491823139398996
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51558,-0.00402315789156261,0.00299222531108304,-0.00988791950128538,0.00184160371816015,0.178788409884105
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51558,-0.00354133456093262,0.00291344572110848,-0.00925168817430525,0.00216901905244,0.224182878348714
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50130,-0.00573574661253948,0.00280118135652223,-0.0112260620713231,-0.000245431153755907,0.0406099915960633
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50130,-0.00497176188688851,0.00307954578004575,-0.0110076716157782,0.00106414784200115,0.106445683549977
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50130,-0.00607242054634684,0.00300552217949458,-0.0119632440181562,-0.000181597074537456,0.0433524301767945
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50130,-0.00613217416597388,0.00274130037066577,-0.0115051228924788,-0.000759225439468969,0.0252995598786209
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24009.Traffic intensity on the nearest road,51558,-0.175916597460957,0.0843653799655579,-0.34127274219345,-0.0105604527284629,0.0370647130069266
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24010.Inverse distance to the nearest road,51558,-0.00107379894517048,0.00260968716186037,-0.0061887857824168,0.00404118789207584,0.680734414835136
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24011.Traffic intensity on the nearest major road,51558,-0.00258249083734533,0.0025832188737595,-0.00764559982991396,0.0024806181552233,0.317457734252313
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24012.Inverse distance to the nearest major road,51558,-0.00249678989738607,0.00263409895830612,-0.00765962385566605,0.00266604406089392,0.34320462117129
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24013.Total traffic load on major roads,51558,0.000930314009247722,0.0502326432097832,-0.0975256666819273,0.0993862947004228,0.985224101166615
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24015.Sum of road length of major roads within 100m,51558,-0.0301592056569007,0.0501495020568806,-0.128452229688387,0.0681338183745852,0.547589054041122
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51558,-0.00112595539285699,0.00297683759075344,-0.00696055707073373,0.00470864628501976,0.705256815784574
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51558,-0.00197798040472689,0.00296946225341986,-0.00779812642142981,0.00384216561197604,0.505349406611507
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51558,-0.00111949088208099,0.00293581283376468,-0.00687368403625976,0.00463470227209779,0.702967735991544
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51506,0.0012097631286231,0.00292714165145523,-0.00452743450822915,0.00694696076547535,0.679396937240586
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24020.Average daytime sound level of noise pollution,51558,-9.59215169376981e-05,0.00263111924114478,-0.00525291522958146,0.00506107219570607,0.970918653127764
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24021.Average evening sound level of noise pollution,51558,-0.000134862964020936,0.00263145007579105,-0.00529250511257138,0.00502277918452951,0.959126420120262
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24022.Average night-time sound level of noise pollution,51558,-9.22035124555034e-05,0.00263115899445404,-0.00524927514158542,0.00506486811667442,0.97204582386419
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51558,-0.00012635802832468,0.00263126445743013,-0.00528363636488774,0.00503092030823838,0.961699305809093
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51558,-0.000105032246422236,0.00263123552017448,-0.00526225386596422,0.00505218937311975,0.968159285084828
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2405.Number of children fathered,39865,0.126374784336108,0.0648850109251575,-0.000799837077200688,0.253549405749417,0.0514802909462052
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49313,0.00280250348906137,0.00308252927115899,-0.00323925388241024,0.00884426086053298,0.363278076376221
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49313,-0.00265343394803873,0.00277075993705634,-0.00808412342466915,0.00277725552859169,0.338247927576558
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24502.Water percentage, buffer 1000m",49313,0.00171069948735379,0.00281277143649906,-0.00380233252818438,0.00722373150289195,0.543068325288081
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49313,0.00248026820207295,0.00288605802574173,-0.00317640552838083,0.00813694193252673,0.39013203261575
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49313,-0.00213656908577153,0.00278191305297405,-0.00758911866960068,0.00331598049805761,0.442483415072055
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24505.Water percentage, buffer 300m",49313,0.00177380114379533,0.00283085211534102,-0.00377466900227308,0.00732227128986373,0.530931077255547
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51698,0.00367138262122315,0.00292536502617982,-0.0020623328300893,0.0094050980725356,0.209485648386413
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51698,0.00202312602452782,0.00273457304806059,-0.00333663714967094,0.00738288919872659,0.459409351445261
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24508.Distance (Euclidean) to coast,51698,0.00152953367594092,0.00258529304067117,-0.00353764068377458,0.00659670803565641,0.554105164077967
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35407,0.0287180112256562,0.0607426031423313,-0.0903374909333131,0.147773513384626,0.63638530331005
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2704.Years since last cervical smear test,38244,-0.0223074161427669,0.0511070013393647,-0.122477138767922,0.077862306482388,0.66249562381041
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2714.Age when periods started (menarche),40629,0.0114059659775605,0.0434286626046507,-0.0737142127275549,0.0965261446826759,0.792835246728362
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2734.Number of live births,40977,0.0326099736877608,0.0422371420051578,-0.0501748246423485,0.11539477201787,0.440089255602853
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2744.Birth weight of first child,39188,-0.0002121229669534,0.0440683425144707,-0.0865860742953161,0.0861618283614093,0.996159493642815
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2754.Age at first live birth,37978,0.00249095992316497,0.00498864489613546,-0.00728678407326054,0.0122687039195905,0.617562270655037
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2764.Age at last live birth,37950,0.00173260658574428,0.00459622472139664,-0.00727599386819314,0.0107412070396817,0.706210247713222
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2794.Age started oral contraceptive pill,36901,0.00400659939984932,0.00723124620455661,-0.0101666431610816,0.0181798419607803,0.579548639938142
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2804.Age when last used oral contraceptive pill,36139,-0.00310452194222879,0.00549613350211198,-0.0138769436063683,0.00766789972191069,0.572190207609108
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2867.Age started smoking in former smokers,36100,-0.000642762134621055,0.00506570585928252,-0.0105715456188148,0.00928602134957268,0.899035105110358
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35930,-0.0451751122792535,0.0696998674966244,-0.181786852572637,0.0914366280141303,0.516917985959938
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35926,-0.0428803717494072,0.0767676134219104,-0.193344894056352,0.107584150557537,0.576471259649126
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35944,0.0229062091505774,0.0756976418468179,-0.125461168869186,0.17127358717034,0.762203006965049
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35917,0.0507441115493339,0.0716869462939535,-0.0897623031868149,0.191250526285483,0.47905856901491
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28739.Difficulty with standing for long periods,35951,0.0786367025438723,0.0570766153007589,-0.0332334634456152,0.19050686853336,0.168329404542311
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28740.Difficulty with taking care of household responsibilities,35973,0.0549605865642126,0.0636714536935298,-0.0698354626751058,0.179756635803531,0.388063350629661
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28741.Difficulty learning a new task,35913,-0.0372019142144614,0.0766366967746167,-0.18740983989271,0.113006011463787,0.627385687100052
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28742.Difficulty with joining in community activities,35651,0.0236778950843622,0.0774808612656101,-0.128184592996234,0.175540383164958,0.759921593286055
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28743.Difficulty with being emotionally affected by health problems,35930,0.0307188138337602,0.0640449317223008,-0.0948092523419495,0.15624688000947,0.631495615712634
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35973,-0.169712597615693,0.124456804302172,-0.413647934047949,0.074222738816564,0.172730443806187
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,35628,-0.00871786619347426,0.0656126639515468,-0.137318687538506,0.119882955151558,0.894301414449002
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2897.Age stopped smoking,36102,0.00513779052842048,0.00476827765669229,-0.0042080336786964,0.0144836147355374,0.281297252564399
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35247,0.00811994949708034,0.012092341661332,-0.0155810401591303,0.031820939153291,0.501930735320083
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35247,-0.0113098605758452,0.0136023676653657,-0.0379705011999619,0.0153507800482716,0.405745121047344
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35247,-0.0287862357578189,0.0445643870034193,-0.116132434284521,0.058559962768883,0.518338113613153
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35247,0.00627504856693685,0.0516396033942667,-0.0949385740858258,0.1074886712197,0.903286214694293
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35247,-0.0111802892285314,0.0648616841841793,-0.138309190229523,0.11594861177246,0.863151440037517
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35247,-0.00786326670707424,0.0528415602794136,-0.111432724854725,0.0957061914405764,0.881709799227972
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35247,0.0129792229054777,0.0221227547302354,-0.0303813763657837,0.0563398221767392,0.557433077491365
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35247,-0.0133027611160326,0.0379274314349193,-0.0876405267284743,0.0610350044964092,0.725793763724822
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29002.Recent lack of interest or pleasure in doing things,35201,0.038949062657969,0.0771721369885885,-0.112308325839665,0.190206451155603,0.613785485171772
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29003.Recent feelings of depression,35192,0.0465868991290611,0.0737348806907881,-0.0979334670248835,0.191107265283006,0.52753101196728
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35206,-0.0892094047687749,0.0624491899514604,-0.211609817073637,0.0331910075360875,0.153196566407627
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29005.Recent feelings of tiredness or low energy,35207,0.0264322890548223,0.0580936635038052,-0.0874312914126358,0.14029586952228,0.649129730716509
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29006.Recent poor appetite or overeating,35218,0.031838129506035,0.0880259388319005,-0.14069271060449,0.20436896961656,0.717596155331135
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29007.Recent feelings of inadequacy,35184,0.0413940513740172,0.0830180391284185,-0.121321305317683,0.204109408065718,0.618068850250952
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29008.Recent trouble concentrating on things,35216,-0.0574130701523721,0.0894424615368552,-0.232720294764608,0.117894154459864,0.520962888075924
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35210,-0.0913938137046525,0.162086151582469,-0.409082670806291,0.226295043396986,0.572870790641865
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29010.Recent thoughts of suicide or self-harm,35190,0.00409206352107709,0.161425906781612,-0.312302713770882,0.320486840813036,0.979777047521853
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29038#0.Substances taken for depression_None of options listed,36225,0.00860453395351776,0.0206797257783346,-0.031927728572018,0.0491367964790535,0.677360142493001
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36225,-0.0289834618409851,0.0524182049657876,-0.131723143573929,0.0737562198919586,0.580330702219195
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36225,0.0322535630448589,0.0211760753087851,-0.00925154456035992,0.0737586706500776,0.127775321865355
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36225,-0.0847886855157795,0.0637122111104073,-0.209664619292178,0.0400872482606187,0.183295529040061
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36225,0.0736629556893705,0.0534657856373469,-0.0311299841598293,0.17845589553857,0.168321624823995
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36225,-0.0397596470496033,0.0565088709179276,-0.150517034048741,0.0709977399495347,0.481705149884816
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36225,-0.037362696432755,0.0579104585589334,-0.150867195208264,0.0761418023427545,0.518831297411391
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36225,-0.0538245256228509,0.0579254201928597,-0.167358349200856,0.059709297955154,0.352815332479206
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36225,0.0519916603699628,0.0377619592449408,-0.0220217797501213,0.126005100490047,0.168609779947454
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36225,-0.0135514631863297,0.0189377271448308,-0.0506694083901982,0.0235664820175387,0.474274345484539
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36225,0.0866763763746735,0.0335330449914208,0.0209516081914888,0.152401144557858,0.00976337061794812
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36225,0.0284876271227485,0.0518699498226704,-0.0731774745296856,0.130152728775182,0.582877038060561
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36225,0.000491707572785868,0.0731060886205929,-0.142796226123576,0.143779641269148,0.99463370315358
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36225,-0.000793288286948364,0.0499021954606581,-0.0986015913898382,0.0970150148159415,0.987317124939194
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36225,0.0807121983278095,0.071726429979453,-0.0598716044319183,0.221296001087537,0.260509514319797
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36225,0.00260932649875064,0.0704374514809188,-0.13544807840385,0.140666731401351,0.970450504244475
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36225,-0.027994573209633,0.0408700181607163,-0.108099808804637,0.052110662385371,0.493387950287873
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36225,-0.0256157400720958,0.037944193528115,-0.0999863593872011,0.0487548792430096,0.499640878360024
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36225,-0.0245787528318867,0.0558411331282478,-0.134027373763252,0.0848698680994789,0.659838393889941
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29058.Recent feelings or nervousness or anxiety,35114,0.0690303821467718,0.0693993704030591,-0.0669923838432239,0.205053148136768,0.319931075255989
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29059.Recent inability to stop or control worrying,35127,0.0354034985830108,0.0730139885485282,-0.107703918972105,0.178510916138126,0.627774754702604
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29060.Recent worrying too much about different things,35124,0.0513001149441667,0.0668377782020691,-0.0797019303318887,0.182302160220222,0.44279600969424
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29061.Recent trouble relaxing,35121,0.0315747795812193,0.0713054157437619,-0.108183835276554,0.171333394438993,0.657919046319678
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29062.Recent restlessness,35137,0.0222117677855732,0.105505091777872,-0.184578212099055,0.229001747670202,0.833262880848913
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29063.Recent easy annoyance or irritability,35109,0.0293317776101601,0.0742484737966444,-0.116195231031263,0.174858786251583,0.692821052422969
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29064.Recent feelings of foreboding,35110,0.103591496484806,0.0772113527044404,-0.0477427548158975,0.254925747785509,0.179757299855042
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36225,-0.00501471726244967,0.0237760858605301,-0.0516158455490886,0.0415864110241893,0.832960232796074
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36225,-0.0222565965353868,0.0421633830212788,-0.104896827257093,0.0603836341863197,0.597609328454451
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36225,0.0141807173971446,0.0508949966857739,-0.0855734761069723,0.113934910901261,0.780539326743307
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36225,-0.0290313472847438,0.0485570273800965,-0.124203120949733,0.0661404263802453,0.549938275958242
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#2.Symptoms of panic attack_Sweating,36225,-0.0326199182044868,0.0361595426176576,-0.103492621735096,0.0382527853261221,0.367028851175822
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36225,-0.00297503750494753,0.0386035037135094,-0.078637904783426,0.0726878297735309,0.938572823586663
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36225,0.00572130502659022,0.0385927617078322,-0.069920507920761,0.0813631179739414,0.882151194839125
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36225,6.82754385861044e-05,0.0390247835937859,-0.0764203004052343,0.0765568512824065,0.998604119009417
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36225,-0.0275329538515482,0.0490758187163116,-0.123721558535519,0.0686556508324226,0.574795697077374
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29076.Felt loved as a child,35106,0.0185395992706753,0.0646141494205848,-0.108104133593671,0.145183332135021,0.77417762221301
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29077.Physically abused by family as a child,35129,-0.131401707619294,0.109163283360355,-0.345361743005591,0.0825583277670023,0.228746983951957
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29078.Felt hated by family member as a child,35115,0.0312091003011395,0.0904523532654879,-0.146077512099217,0.208495712701496,0.730081379112243
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29079.Sexually molested as a child,35070,-0.17875266189785,0.145697098563376,-0.464318975082066,0.106813651286366,0.219917378679106
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29080.Someone to take to doctor when needed as a child,35087,0.0150906638477331,0.0921260310523162,-0.165476357014807,0.195657684710273,0.869890623181735
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35121,-0.148412184522247,0.162683307809564,-0.467271467828992,0.170447098784498,0.361660208260643
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35075,-0.233734533583596,0.132494531961428,-0.493423816227995,0.0259547490608031,0.0777658807154448
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35125,-0.0709160860474676,0.131422773600943,-0.328504722305316,0.186672550210381,0.589491300945971
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35113,-0.178573903829033,0.204096452845079,-0.578602951405388,0.221455143747323,0.381637385493343
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35112,-0.0588064578208407,0.168634915689462,-0.389330892572186,0.271717976930505,0.727311534452408
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29086.Experienced a violent or sexual assault,35128,-0.151134863590985,0.173525514493522,-0.491244871998288,0.188975144816319,0.383807830353968
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29087.Experienced a life-threatening injury or illness,35120,-0.118143977702988,0.077496070070479,-0.270036275041127,0.0337483196351512,0.127433302245823
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29088.Experienced a marital separation or divorce,35128,0.0387850452565035,0.0701102881669768,-0.098631119550771,0.176201210063778,0.580146980234207
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29089.Experienced the death of a spouse or partner,35134,0.124333310270098,0.0723543260074136,-0.0174811687044321,0.266147789244629,0.0857767147311866
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35126,0.0973722590424006,0.0831142619069109,-0.0655316942951448,0.260276212379946,0.24142606356281
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29091.Frequency of drinking alcohol,35124,-0.0164766469649333,0.0579393887807322,-0.130037848975168,0.0970845550453018,0.776131187342463
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34400,-0.0151415138753429,0.0711739773706746,-0.154642509521865,0.124359481771179,0.831538516703582
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34423,-0.0244800240782797,0.0739584251625737,-0.169438537396924,0.120478489240365,0.740659948204895
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29104.Ever used cannabis,35125,0.0735183304510961,0.0987806438432659,-0.120091731481705,0.267128392383897,0.456749623714721
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29108.Ever thought that life not worth living,35096,-0.0437874299140252,0.0816152303880269,-0.203753281474558,0.116178421646508,0.591625990017518
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29109.Ever contemplated self-harm,35117,-0.0788369547970378,0.128660941046532,-0.331012399248241,0.173338489654165,0.540065374323102
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29111.Ever self-harmed,35125,0.0616819476520257,0.186642810929147,-0.304137961769102,0.427501857073153,0.741048040326881
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35113,0.00605841810737172,0.118678178611385,-0.226550811970943,0.238667648185687,0.959288092053776
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36849,-0.0491456155329909,0.0562335544404111,-0.159363382236197,0.0610721511702149,0.382169988060703
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36849,0.0169065862577553,0.0410982307667752,-0.0636459460451241,0.0974591185606347,0.680812638474015
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36849,-0.0330382171210561,0.0493377998561719,-0.129740304839153,0.0636638705970408,0.503111992161448
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36849,-0.0651693545468446,0.0696586094120652,-0.201700228994492,0.0713615199008032,0.349532646605643
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35105,-0.0342765041313267,0.0664462495455249,-0.164511153240556,0.0959581449779021,0.605976306343597
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X29153.Pain or discomfort today,35116,-0.0680952828593488,0.0604715557061312,-0.186619532043366,0.0504289663246683,0.260180998186586
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29154.Anxiety or depression today,35116,0.00795543379887285,0.0769720054854408,-0.142909696952591,0.158820564550337,0.917684807776741
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29166.Frequency of confiding in someone close,34940,-0.0567976024644718,0.0595539405922747,-0.17352332602533,0.0599281210963866,0.340267084998994
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35097,-0.00487222508197625,0.0115870249694259,-0.027582794022051,0.0178383438580985,0.67414303132357
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35097,0.0061749108850655,0.011842876153987,-0.017037126376749,0.02938694814688,0.602105638213746
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35097,0.0140766727312681,0.0147986425837798,-0.0149286667329404,0.0430820121954765,0.341534809442317
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35097,-0.0107475127009324,0.0137423423782024,-0.0376825037622091,0.0161874783603444,0.434203137019397
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35097,-0.0226006763930561,0.0234716506208379,-0.0686051116098983,0.0234037588237861,0.335640914357466
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35097,-0.00176182381246877,0.011190717207955,-0.0236956295400606,0.020171981915123,0.874906482977344
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35095,0.00199433863026357,0.01203832772768,-0.0216007837159893,0.0255894609765165,0.868425673707658
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35095,-0.0268921906580034,0.0184515477670084,-0.0630572242813399,0.00927284296533316,0.145045679383592
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35095,0.027658056833512,0.0267836633129732,-0.0248379232599155,0.0801540369269395,0.301811666389609
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35095,-0.0103354988924811,0.0216508934859405,-0.0527712501249245,0.0321002523399624,0.633115962149437
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35095,-0.0251551012891874,0.0356736253257985,-0.0950754069277524,0.0447652043493777,0.480747439104701
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35095,0.000208548427243537,0.0163261902699052,-0.0317907845017707,0.0322078813562577,0.989808645345892
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29171.Frequency of feeling 'in tune' with people,34997,0.13768635761128,0.0861187136202301,-0.0311063210843713,0.306479036306931,0.109920123789108
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29172.Freuency of feeling that lacks companionship,35080,0.0455860937121414,0.0669787224958352,-0.0856922023796956,0.176864389803978,0.496147857145627
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29173.Frequency of feeling left out,35038,-0.0316103160871328,0.0753442130150829,-0.179284973596695,0.11606434142243,0.674833024906464
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29174.Frequency of feeling isolated from others,35070,-0.0244502081132804,0.077975081979871,-0.177281368793827,0.128380952567267,0.753863049704787
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29175.Tendency to bounce back quickly after hard times,35111,0.110773337392485,0.0588194890186268,-0.00451286108402371,0.226059535868993,0.0597119922299871
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29176.Ability to make it through stressful events,35111,0.126339805430089,0.0576897434532215,0.0132679082617753,0.239411702598404,0.0285640803825879
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29177.Quick recovery from stressful events,35111,0.07433711353219,0.0587405559036035,-0.0407943760388727,0.189468603103253,0.205736270272307
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29178.Hard to snap back when something bad happens,35111,-0.0719516940975037,0.0567614423057168,-0.183204121016709,0.0393007328217012,0.20498513762799
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29179.Comes through difficult times with little trouble,35111,0.0692535573462248,0.0577208495134331,-0.0438793077001042,0.182386422392554,0.230264533977453
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29180.Tendency to take a long time to get over setbacks,35111,-0.0459654829169662,0.0575852916690133,-0.158832654588232,0.0669016887542998,0.424777388613259
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29181.General happiness,35084,0.0608864427348927,0.0599376831673231,-0.0565914162730606,0.178364301742846,0.309752529346803
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29182.Belief that own life is meaningful,34991,-0.0651732566641013,0.061751183824685,-0.186205576960484,0.0558590636322814,0.291278601710698
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,35446,-0.0120878703638149,0.0603366517193361,-0.130347707733714,0.106171967006084,0.841220866086664
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2946.Father's age,30155,0.0038252211677827,0.0214788045513693,-0.0382732357529011,0.0459236780884664,0.858687603381177
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2966.Age high blood pressure diagnosed,36656,-0.00367686542596217,0.00462515881618077,-0.0127421767056765,0.00538844585375214,0.426655869812668
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30000.White blood cell (leukocyte) count,51119,-0.00410111260063674,0.00284742888375264,-0.00968207321279192,0.00147984801151843,0.149800715575121
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51120,0.00626781042077111,0.00299855779711083,0.000390637138433886,0.0121449837031083,0.0366045920104153
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30020.Haemoglobin concentration,51120,0.00685265663160739,0.00322547250028985,0.000530730531039285,0.0131745827321755,0.0336358787632934
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30030.Haematocrit percentage,51120,0.00706227356562897,0.00313557058416833,0.000916555220659039,0.0132079919105989,0.0243126067469341
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30040.Mean corpuscular volume,51120,2.46155627133751e-05,0.00275201652033042,-0.00536933681713424,0.005418567942561,0.992863454318961
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51120,-0.0013804175404923,0.00276130413709821,-0.0067925736492048,0.0040317385682202,0.617139900005192
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51120,-0.00216868288694742,0.0026993675434883,-0.0074594432721845,0.00312207749828965,0.421749929119166
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51120,0.00488365015408697,0.00278624765678747,-0.00057739525321647,0.0103446955613904,0.0796555406812737
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30080.Platelet count,51120,0.00269861673438247,0.00273532462307206,-0.00266261952683877,0.0080598529956037,0.323859435367558
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30090.Platelet crit,51120,0.00154777448163841,0.00278615839859081,-0.00391309597959958,0.0070086449428764,0.578542795410821
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51120,-0.00325052699395167,0.00260545640290139,-0.0083572215436384,0.00185616755573506,0.212196586099895
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30110.Platelet distribution width,51120,0.000106985652583162,0.0027018225426737,-0.00518858653105729,0.00540255783622361,0.968414311924538
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30120.Lymphocyte count,51081,-0.00457441517576694,0.00268593447464329,-0.00983884674606778,0.000690016394533902,0.0885635414986202
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30130.Monocyte count,51081,-0.0027516538618087,0.00274283295115609,-0.00812760644607463,0.00262429872245724,0.315767752658051
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30140.Neutrophill count,51081,-0.00321464416602899,0.00282085872124831,-0.00874352725967568,0.00231423892761769,0.254466407200241
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30150.Eosinophill count,51081,-0.00294530015469877,0.00269721450871804,-0.00823184059178612,0.00234124028238858,0.274854587276829
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30160.Basophill count,51081,0.00394693522229492,0.0352219943107852,-0.0650881736268441,0.072982044071434,0.910777793959024
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30170.Nucleated red blood cell count,51081,-0.235962582243883,0.222732509260356,-0.67251830039418,0.200593135906415,0.289429827758519
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30180.Lymphocyte percentage,51082,-0.00137384797000351,0.0026727743040692,-0.00661248560597914,0.00386478966597212,0.607246199211871
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30190.Monocyte percentage,51082,0.000147286531374824,0.00270940842706325,-0.00516315398566914,0.00545772704841879,0.956647934810534
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30200.Neutrophill percentage,51082,0.000989583330692082,0.00265309084167826,-0.0042104747189973,0.00618964138038146,0.709157541074872
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30210.Eosinophill percentage,51082,-0.00149208752798921,0.00267479062123689,-0.00673467714561351,0.00375050208963509,0.576963862894657
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30220.Basophill percentage,51082,-0.00305009180124699,0.00266679779940332,-0.00827701548807749,0.0021768318855835,0.252748889871196
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30230.Nucleated red blood cell percentage,51081,-0.236890963655619,0.222885370885147,-0.673746290590507,0.19996436327927,0.287867309476732
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30240.Reticulocyte percentage,50740,-0.000757788448030038,0.00289233015455434,-0.00642675555095655,0.00491117865489647,0.793324493880593
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30250.Reticulocyte count,50740,0.000364079301209706,0.00294377927749194,-0.0054057280826745,0.00613388668509391,0.901571770252103
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30260.Mean reticulocyte volume,50740,0.00296739153791159,0.00270877810137395,-0.00234181354078135,0.00827659661660454,0.273321993327212
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30270.Mean sphered cell volume,50740,-0.000262080977496675,0.0027436368351992,-0.00563960917448711,0.00511544721949376,0.923900149797119
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30280.Immature reticulocyte fraction,50740,0.000766517172786923,0.00285773672846303,-0.00483464681500062,0.00636768116057446,0.788528501416857
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50740,-0.000161793671255888,0.00294644884021178,-0.00593683339807098,0.00561324605555921,0.956209547897081
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30300.High light scatter reticulocyte count,50740,0.000987062699440015,0.00298601024545003,-0.00486551738164204,0.00683964278052207,0.740978269050579
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30500.Microalbumin in urine,36959,-0.00367595885378329,0.00398519700435717,-0.0114869449823234,0.00413502727475676,0.356346909710697
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51108,2.2950290515341e-05,0.00292905746819207,-0.00571800234714112,0.0057639029281718,0.993748403235298
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30520.Potassium in urine,51071,-0.000991592184859749,0.00274369617481022,-0.00636923668748777,0.00438605231776827,0.717798384164262
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30530.Sodium in urine,51054,0.00180148051052774,0.00286797468982355,-0.00381974988152642,0.0074227109025819,0.529920874482491
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30600.Albumin,48916,0.0079166291923813,0.0029492418622744,0.00213611514232347,0.0136971432424391,0.00727440996453991
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30610.Alkaline phosphatase,50696,-0.000453200145922816,0.00284684422985882,-0.0060330148364461,0.00512661454460047,0.873517629672808
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30620.Alanine aminotransferase,50700,-0.00526840581859633,0.0030427661949431,-0.0112322275606848,0.000695415923492138,0.0833853906234772
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30630.Apolipoprotein A,48774,0.00138416081873611,0.00323631381584442,-0.00495901426031896,0.00772733589779118,0.668876638530202
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30640.Apolipoprotein B,50601,0.007580902739195,0.00264451191192335,0.00239765939182524,0.0127641460865648,0.00415239791352454
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30650.Aspartate aminotransferase,50635,-0.00780803576090995,0.00290373120441268,-0.0134993489215588,-0.00211672260026111,0.00717290399107503
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30660.Direct bilirubin,47558,-0.00200633065812211,0.00299827996806517,-0.00788295939552984,0.00387029807928561,0.503401483625635
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30670.Urea,50684,-0.00415466550617375,0.00280468392058333,-0.00965184599051708,0.00134251497816958,0.138533027509612
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30680.Calcium,48916,0.00223165295940408,0.00285459052696026,-0.00336334447343804,0.00782665039224619,0.434355078540947
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30690.Cholesterol,50702,0.0092489707790497,0.00267452457244743,0.00400690261705274,0.0144910389410467,0.000544902653656373
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30700.Creatinine,50693,-0.00156614766144722,0.00311212569010584,-0.00766591401405468,0.00453361869116023,0.614800355232075
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30710.C-reactive protein,50640,-0.000539345739982644,0.00303556206724787,-0.00648904739178847,0.00541035591182319,0.858979315921771
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30720.Cystatin C,50709,0.000406840025747677,0.00308385670935741,-0.00563751912459284,0.0064511991760882,0.895044276121983
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30730.Gamma glutamyltransferase,50696,-0.00241240793471822,0.00305427241416462,-0.00839878186648088,0.00357396599704444,0.429625830932892
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30740.Glucose,48899,-0.00181114928060172,0.0029242241499341,-0.00754262861447256,0.00392033005326911,0.535685978794438
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50667,-0.0038771645683573,0.0028543334305061,-0.00947165809214926,0.00171732895543466,0.174369060625525
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30760.HDL cholesterol,48906,0.00265373405953265,0.00331616509671922,-0.00384594953003703,0.00915341764910233,0.42358033650339
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30770.IGF-1,50574,0.00384936358946991,0.00279331289213853,-0.00162552967912161,0.00932425685806142,0.168197989423282
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30780.LDL direct,50651,0.00917043647849874,0.00262133591952134,0.00403261807623691,0.0143082548807606,0.000469036553098545
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30790.Lipoprotein A,46343,0.00331852145715267,0.00297319765863039,-0.00250894595376291,0.00914598886806824,0.264375458649773
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30810.Phosphate,48879,-0.00262370548456135,0.00305163558039447,-0.00860491122213452,0.00335750025301181,0.389926172073944
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30830.SHBG,48748,0.00477250435768585,0.00355706768589526,-0.00219934830666887,0.0117443570220406,0.179710085357105
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30840.Total bilirubin,50613,0.000464477843768455,0.00294581442770956,-0.00530931843454227,0.00623827412207918,0.874715309303251
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30850.Testosterone,48187,0.00574925409752101,0.00464283798913789,-0.00335070836118925,0.0148492165562313,0.215617928379163
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30860.Total protein,48902,-0.000938113680550964,0.00286741359984987,-0.00655824433625672,0.00468201697515479,0.743547539371662
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30870.Triglycerides,50688,0.00120207291462952,0.00305882146279841,-0.00479321715245536,0.0071973629817144,0.694333983830406
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30880.Urate,50673,0.000679288743599213,0.00327964245922947,-0.00574881047649054,0.00710738796368897,0.835915916347592
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30890.Vitamin D,49608,-0.000590805546191654,0.00303709334455439,-0.00654350850151825,0.00536189740913494,0.845762900778985
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X3137.Number of measurements made,49297,0.0200543636100092,0.0421805896580821,-0.0626195921198317,0.10272831933985,0.634478149049185
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X3143.Ankle spacing width,41989,-0.00623281275287308,0.00467476585130724,-0.0153953538214353,0.00292972831568912,0.182460798407117
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",41988,6.02970491486088e-05,0.00364919003796116,-0.00709211542525527,0.00721270952355249,0.986817086870208
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X3146.Speed of sound through heel,41989,-0.00224001516121651,0.00349828341668753,-0.00909665065792406,0.00461662033549104,0.521977101679573
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",41989,-0.00145367299689839,0.00354113065614795,-0.00839428908294837,0.00548694308915159,0.681438028465275
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X3148.Heel bone mineral density (BMD),41977,-0.0016370892161222,0.00354906527113186,-0.00859325714754065,0.00531907871529625,0.644610352991899
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X3526.Mother's age at death,47921,0.00143230695457641,0.00273211381742214,-0.00392263612757098,0.0067872500367238,0.600111818558455
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X3581.Age at menopause (last menstrual period),38292,0.000403650927358991,0.00405637866146283,-0.00754685124910816,0.00835415310382614,0.920735406224641
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32726,-0.0101687497722304,0.00555624564894983,-0.0210589912441721,0.000721491699711285,0.0673120986693963
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4100.Ankle spacing width (left),36585,-0.00498976086087418,0.00619587292430124,-0.0171336717925046,0.00715415007075625,0.420651594546457
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36582,0.003593899160651,0.00482218136063896,-0.00585757630620137,0.0130453746275034,0.456123190109772
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4103.Speed of sound through heel (left),36585,0.0037705348591891,0.00459409337059424,-0.00523388814717561,0.0127749578655538,0.411823496730006
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36585,0.00366100217744004,0.00465784995409814,-0.00546838373259232,0.0127903880874724,0.431901222770199
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4105.Heel bone mineral density (BMD) (left),36582,0.00348992888251639,0.00465000480652376,-0.00562408053827017,0.012603938303303,0.452964542577878
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36585,0.00366122805444081,0.00465783002242317,-0.0054681187895086,0.0127905748983902,0.431870844216932
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4119.Ankle spacing width (right),36588,-0.00371485234265245,0.0061605911539728,-0.0157896110044391,0.00835990631913424,0.546525469292306
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36587,-0.000736825013210419,0.00485243535659725,-0.010247598312141,0.00877394828572019,0.879312199721767
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4122.Speed of sound through heel (right),36588,0.0029180730190915,0.00462457573739099,-0.00614609542619483,0.0119822414643778,0.528064873383672
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36588,0.00155047090244704,0.00469057938260599,-0.00764306468746071,0.0107440064923548,0.740993802877404
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4124.Heel bone mineral density (BMD) (right),36584,0.00144302557069392,0.00468318075161889,-0.00773600870247911,0.010622059843867,0.757992572170976
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36588,0.0015508587538872,0.0046905670554142,-0.00764265267472464,0.010744370182499,0.740930682575973
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4194.Pulse rate,36930,0.00235196095229583,0.004398911621953,-0.00626990582673204,0.0109738277313237,0.592894241460155
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4195.Pulse wave reflection index,36930,-0.000401725910369313,0.00477171462301957,-0.00975428657148768,0.00895083475074905,0.932908337619311
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4196.Pulse wave peak to peak time,36924,-0.00603561246871785,0.0043475741975759,-0.0145568578959666,0.00248563295853093,0.165094454699361
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4198.Position of the pulse wave peak,36930,0.00506291434117065,0.00464109332988893,-0.00403362858541165,0.0141594572677529,0.275356018384718
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4199.Position of pulse wave notch,36930,-0.00334794554073281,0.00443916100420374,-0.0120487011089721,0.00535281002750651,0.4507615180618
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4200.Position of the shoulder on the pulse waveform,36930,0.00626376697761421,0.00456870831705878,-0.002690901323821,0.0152184352790494,0.170410096034617
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4269.Number of triplets attempted (left),36745,-0.309373587402078,0.105285232931272,-0.51573264394737,-0.103014530856786,0.00330876169275066
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4270.Volume level set by participant (left),36654,0.00032085318250551,0.0546329239705582,-0.106759677799788,0.107401384164799,0.995314295342336
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4276.Number of triplets attempted (right),36742,-0.269417704277131,0.107020710850607,-0.479178297544321,-0.0596571110099413,0.0118418436034734
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4277.Volume level set by participant (right),36647,-0.0274509247704372,0.0537254093506118,-0.132752727097636,0.0778508775567619,0.609402162287327
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X4288.Time to answer,36931,0.00298323449634859,0.00521267898453723,-0.00723361631334439,0.0132000853060416,0.56713299826825
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X4290.Duration screen displayed,36931,0.00620902920170597,0.00492021194180697,-0.0034345862042357,0.0158526446076476,0.207007178271363
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X46.Hand grip strength (left),51699,0.00295738471367992,0.00380028489024077,-0.00449117367119199,0.0104059430985518,0.43645883092228
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X47.Hand grip strength (right),51725,0.00225451102296849,0.00377799849113116,-0.00515036601964858,0.00965938806558556,0.550681993299816
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X48.Waist circumference,51786,0.00370146733870254,0.00576641019214945,-0.00760069663791039,0.0150036313153155,0.520943654477833
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X4803.Tinnitus,36841,-0.058818755933609,0.0656186337817168,-0.187431278145774,0.069793766278556,0.370081937786545
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X4825.Noisy workplace,36913,0.0332593599395342,0.0710805297740526,-0.106058478417609,0.172577198296677,0.639861468963309
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X4836.Loud music exposure frequency,36873,-0.0339040957580499,0.126257099277603,-0.281368010342152,0.213559818826052,0.788296913400441
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X49.Hip circumference,51781,0.00293809608339052,0.00470745243750209,-0.00628851069411358,0.0121647028608946,0.532543802774803
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X50.Standing height,51762,0.00284093488117287,0.00373636329934765,-0.00448233718554853,0.0101642069478943,0.447054777277877
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X5057.Number of older siblings,35719,0.0321730895842007,0.0603767064402016,-0.0861652550385944,0.150511434206996,0.594139957054067
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X51.Seated height,51674,-5.0229844692144e-05,0.00349441567357854,-0.00689928456490608,0.00679882487552179,0.988531475512751
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5181.Ever had eye surgery,34398,0.177705572759566,0.103803517673223,-0.0257493218799501,0.381160467399082,0.0869670119537479
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5186.Duration visual-acuity screen displayed (right),34384,0.0025135558161548,0.00527300224022091,-0.00782152857467818,0.0128486402069878,0.633607224189634
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5188.Duration visual-acuity screen displayed (left),34384,-0.00200173418069807,0.00542215817079431,-0.0126291641954549,0.00862569583405878,0.712011120441618
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5190.Duration at which refractometer first shown (right),34312,-0.00373664992325344,0.00558418167098221,-0.0146816459983786,0.00720834615187169,0.503430578728347
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5193.Duration at which refractometer first shown (left),34311,0.00180539225966806,0.00562990368658084,-0.0092292189660304,0.0128400034853665,0.748466707477292
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5199.logMAR, initial (right)",34367,-0.0129994204729644,0.0700802736109147,-0.150356756750357,0.124357915804429,0.852849416997123
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5200.Final number of letters displayed (right),34367,-0.363647405702141,0.248431961162646,-0.850574049580927,0.123279238176645,0.143317416423368
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5201.logMAR, final (right)",34310,8.14162109646758e-05,0.00582943161060529,-0.0113442697458217,0.011507102167751,0.988857326815645
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5202.Number of rounds to result (right),34367,-0.0651480413304178,0.0641955524501922,-0.190971324132794,0.0606752414719589,0.310230951952327
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5206.logMAR, initial (left)",34364,-0.0505944026166838,0.0708434828334974,-0.189447628970339,0.0882588237369711,0.47515333087249
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5207.Final number of letters displayed (left),34364,-0.0957472672583747,0.346753787679137,-0.775384691109483,0.583890156592734,0.782463371592133
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5208.logMAR, final (left)",34303,0.00207012340995419,0.00584006452329786,-0.00937640305570962,0.013516649875618,0.723001859194992
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5209.Number of rounds to result (left),34362,-0.143365498049014,0.0650456031549056,-0.270854880232629,-0.0158761158653992,0.0275629712846911
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",34114,0.0100564842678092,0.00546021526643062,-0.000645537654394865,0.0207585061900132,0.0655683194156857
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",34114,0.00977021067611377,0.00552423420383632,-0.00105728836340542,0.020597709715633,0.0770210895283163
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5256.Corneal hysteresis (right),34114,-0.00650576147892464,0.00552498154586225,-0.0173347253088146,0.00432320235096536,0.239046044046636
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5257.Corneal resistance factor (right),34114,0.00155892259525351,0.00557410043138946,-0.00936631425026984,0.0124841594407769,0.779740535983084
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",34110,0.0088941930988386,0.00547936822882284,-0.00184536862965417,0.0196337548273314,0.104607553725937
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",34110,0.00770426853714294,0.00552466992897958,-0.00312408452365704,0.0185326215979429,0.163223328578472
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5264.Corneal hysteresis (left),34110,-0.001846559005921,0.0056378723988961,-0.0128967889077574,0.00920367089591535,0.74328279231902
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5265.Corneal resistance factor (left),34110,0.00292569082332789,0.00565295437289374,-0.00815409974754384,0.0140054813941996,0.604795032578032
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34499,-0.184425388728086,0.446234862427038,-1.05904571908508,0.690194941628908,0.67940925045634
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51725,-0.016481768856346,0.0140245584589737,-0.0439699034359346,0.0110063657232425,0.239924056006024
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51725,0.00234477076026342,0.0150473248173608,-0.0271479858817637,0.0318375274022905,0.876171240678208
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51725,0.00315438319520422,0.040267951219241,-0.0757708011945082,0.0820795675849166,0.937562406249471
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51725,0.00522750756796865,0.00607005612180806,-0.00666980243077516,0.0171248175667125,0.389139311201269
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51725,-0.00135988764822386,0.00571616378797847,-0.0125635686726617,0.00984379337621395,0.811959152124639
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38104,0.0019252087106413,0.00782794603578814,-0.0134175655195034,0.0172679829407861,0.805733981829301
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38104,-0.00686268396006986,0.0167564315597998,-0.0397052898172775,0.0259799218971378,0.68214209923881
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38104,0.00590567344597045,0.0206048831474295,-0.0344798975229915,0.0462912444149324,0.77441361117752
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38104,-0.00764666988258743,0.0111183304605735,-0.0294385975853115,0.0141452578201366,0.491625971441508
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51795,0.0158245335036705,0.0118730326910432,-0.0074466105707742,0.0390956775781152,0.182606581417896
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51795,0.0158245335036705,0.0118730326910432,-0.0074466105707742,0.0390956775781152,0.182606581417896
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51795,0.00336924515875507,0.00950827931535349,-0.0152669822993378,0.0220054726168479,0.723080979789903
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51795,0.00688767845338993,0.0163927352103861,-0.0252420825589668,0.0390174394657466,0.674367807560274
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51795,0.0287210791658884,0.0387050503750059,-0.0471408195691232,0.1045829779009,0.458064807602927
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51795,-0.00216865688279348,0.0267070620391985,-0.0545144984796225,0.0501771847140356,0.935282324859647
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51795,0.0634734846272276,0.0437319244292616,-0.0222410872541252,0.14918805650858,0.146676219999996
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51725,-0.00406074742719491,0.00877785749353095,-0.0212653481145156,0.0131438532601258,0.643646547092354
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51725,0.0253800529292801,0.0148558869843758,-0.00373748556009646,0.0544975914186567,0.0875727305949305
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51725,0.00789809639278709,0.0087832125783767,-0.00931700026083124,0.0251131930464054,0.368541705280296
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51725,-0.0070440601959389,0.0124033961633137,-0.0313547166760338,0.017266596284156,0.570099141026416
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51725,-0.00841438090230806,0.0150975362341585,-0.0380055519212587,0.0211767901166426,0.577304304807399
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51725,0.00199124967169624,0.00587278112084412,-0.00951940132515824,0.0135019006685507,0.734564547446736
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,38685,0.00305376368745181,0.0132634787233902,-0.022942654610393,0.0290501819852966,0.817911394579191
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,38685,0.00320993722329339,0.0113443934344588,-0.0190250739082459,0.0254449483548327,0.777218558991499
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,38685,-0.0226415623678456,0.0163201462074812,-0.0546290489345087,0.00934592419881745,0.165371232456518
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,38685,-0.000988243253815451,0.0128371003031716,-0.0261489598480317,0.0241724733404008,0.93863839651245
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51713,-0.012554891937301,0.020009915773807,-0.0517743268539626,0.0266645429793607,0.530381461190001
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51713,-0.021239503888994,0.0309350181847476,-0.0818721395310992,0.0393931317531113,0.492351670373493
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51713,0.028733242685503,0.0495456016121825,-0.0683761364743747,0.125842621845381,0.561964060664395
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51713,0.0049248090786921,0.0507774636495339,-0.0945990196743943,0.104448637831779,0.922736717901311
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51713,0.00761010711484526,0.016488232441232,-0.0247068284699695,0.03992704269966,0.644410106542985
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51713,-0.0418321310025921,0.0228496531473409,-0.0866174511713802,0.00295318916619597,0.0671502339077816
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51713,-0.0164499475279911,0.0121115138267432,-0.0401885146284079,0.0072886195724256,0.174411494560284
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35871,0.017188440164239,0.0151990749792635,-0.0126017467951176,0.0469786271235955,0.258143166532695
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35871,0.023118282544651,0.0160408479350256,-0.00832177940799904,0.0545583444973011,0.14957134096988
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35871,0.0116677180754892,0.0221946827588043,-0.0318338601317671,0.0551692962827456,0.599114955968845
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35871,-0.00134668321352979,0.00932242765662153,-0.019618641420508,0.0169252749934484,0.885144538098112
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",40329,0.0045152816380178,0.00744158051813123,-0.0100702161775194,0.019100779453555,0.544020048938187
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",40329,0.00379695504252721,0.00880101436949511,-0.0134530331216832,0.0210469432067376,0.66616959280269
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",40329,-0.00348674958229814,0.00728354728623099,-0.0177625022633109,0.0107890030987146,0.632150182967057
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",40329,-0.00396323825337683,0.0167438749672756,-0.036781233189237,0.0288547566824833,0.812895601130259
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",40329,-0.00321781614895866,0.00936585180838293,-0.0215748856933892,0.0151392533954719,0.731176943466098
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",40329,0.0027378632837093,0.0133593818374034,-0.0234465251176013,0.02892225168502,0.83762324188166
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51725,-0.0062984669396759,0.0163649406255282,-0.0383737505657111,0.0257768166863593,0.700333190141319
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51725,-0.00469694392889255,0.0123763128913426,-0.028954517195924,0.0195606293381389,0.704312191194932
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51725,-0.0399928253632232,0.0313432424133477,-0.101425580493385,0.0214399297669383,0.201981664864853
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51725,-0.00786441453568563,0.0115576944930702,-0.0305174957421032,0.0147886666707319,0.49622758600514
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51725,-0.0154127285363029,0.0136312993251052,-0.0421300752135091,0.0113046181409033,0.258199026415548
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51725,-0.0146572076881205,0.0163349681896556,-0.0466737453398455,0.0173593299636046,0.369573645354237
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51725,0.00374806392416147,0.00548846884027255,-0.00700933500277272,0.0145054628510957,0.494678373318308
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34788,-0.0295829817984654,0.0150182547293592,-0.0590187610680094,-0.000147202528921472,0.0489103662927476
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34788,-0.0216162410415578,0.0184450422371287,-0.0577685238263301,0.0145360417432145,0.241276308748504
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34788,0.0110015769078643,0.0128952835983476,-0.014273178944897,0.0362763327606256,0.393614122417125
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34788,-0.00667146461145235,0.0120750095692661,-0.0303384833672139,0.0169955541443092,0.580626666913139
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51819,-0.000835531124974922,0.00731491002238785,-0.0151727547688551,0.0135016925189053,0.909062016334921
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51819,-0.0210626739694972,0.0202851826680028,-0.0608216319987826,0.0186962840597882,0.299128454809844
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51819,-0.0105357976700697,0.0060885307493055,-0.0224693179387085,0.00139772259856908,0.083566485609956
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51819,0.0042534570691798,0.00586140157930035,-0.00723489002624888,0.0157418041646085,0.468047160926721
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51819,-0.00963818407237468,0.0100019880987721,-0.0292420807459679,0.00996571260121856,0.335243350089585
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51819,-0.00135935093333236,0.00748724339209797,-0.0160343479818444,0.0133156461151797,0.855933125562526
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51819,-0.00460285256197538,0.006128390773923,-0.0166144984788645,0.00740879335491371,0.452618134340743
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51819,-0.00731790759509872,0.0188772718821252,-0.0443173604840641,0.0296815452938666,0.698273488277157
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45278,-0.00174595663350049,0.0063080241965381,-0.0141096840587152,0.0106177707917142,0.781949954637861
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45278,0.000304561903271439,0.00655030032287541,-0.0125340267295644,0.0131431505361072,0.96291560413807
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45278,-0.00674453571195394,0.0069331163894144,-0.0203334438352062,0.00684437241129828,0.33066733577226
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45278,0.0155489753654965,0.00948621030272109,-0.00304399682783684,0.0341419475588298,0.101209181983069
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45278,0.00307668000620866,0.0063239113999597,-0.00931818633771234,0.0154715463501297,0.626608449425988
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51595,0.00329631466659171,0.00645234268741726,-0.00935027700074611,0.0159429063339295,0.609446433715489
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51595,0.00633416605573805,0.00523318900929141,-0.00392288440247311,0.0165912165139492,0.226144510049662
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51595,-0.00175659905820787,0.00541898828503126,-0.0123778160968691,0.0088646179804534,0.745822750011606
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51595,0.000103841123392318,0.0117605394176947,-0.0229468161352894,0.023154498382074,0.992955150700162
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51614,0.00469974609834843,0.00581856429378058,-0.00670463991746151,0.0161041321141584,0.41926279652905
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51614,-0.00227940052185118,0.0114755662686264,-0.0247715104083589,0.0202127093646566,0.842553386135539
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51725,0.00174126314512205,0.00530415057957419,-0.00865487199084337,0.0121373982810875,0.742700650297617
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51725,-0.0116580657412975,0.00608394816880904,-0.0235826041521633,0.00026647266956817,0.0553521930937285
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51725,0.000951338274289527,0.00920752061806743,-0.0170954021371226,0.0189980786857017,0.917708436086704
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51725,0.00565392600851631,0.0127153243602069,-0.0192681097374892,0.0305759617545219,0.656573737230095
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51725,-0.0129754061667104,0.0160465609990136,-0.0444266657247771,0.0184758533913563,0.418748175092234
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51725,-0.00242153758060938,0.0151412689990182,-0.0320984248186851,0.0272553496574664,0.872937939545735
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",41989,-0.00145394837788572,0.0035411199902297,-0.00839454355873593,0.00548664680296449,0.681380089255841
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X864.Number of days or week walked 10+ minutes,51239,0.0406132414258975,0.0328960219671722,-0.0238629616297599,0.105089444481555,0.216994692009632
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X874.Duration of walks,48214,-0.000197041586538877,0.00292232772834043,-0.00592480393408611,0.00553072076100836,0.946243084649262
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50314,-0.00281833406327021,0.0307586930762323,-0.0631053724926855,0.0574687043661451,0.926995079640263
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X894.Duration of moderate activity,45558,0.0300121509689486,0.0394057026277103,-0.0472230261813636,0.107247328119261,0.446298118148673
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X90087.No-wear time bias adjusted average acceleration,33363,0.000929698051361149,0.00622180714604241,-0.011265043954882,0.0131244400576043,0.881224940735168
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50227,0.0400436654100637,0.0320281114854403,-0.0227314331013992,0.102818763921527,0.211216232793402
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X914.Duration of vigorous activity,40152,0.0013702944507257,0.00351103768567056,-0.00551133941318859,0.00825192831463999,0.696335693753708
